CN108837173A - A kind of eccentric sexual oppression dressing and its production method being closed after treatment for vein - Google Patents
A kind of eccentric sexual oppression dressing and its production method being closed after treatment for vein Download PDFInfo
- Publication number
- CN108837173A CN108837173A CN201810714443.5A CN201810714443A CN108837173A CN 108837173 A CN108837173 A CN 108837173A CN 201810714443 A CN201810714443 A CN 201810714443A CN 108837173 A CN108837173 A CN 108837173A
- Authority
- CN
- China
- Prior art keywords
- parts
- hemostatic
- vitamin
- fabric
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Animal Husbandry (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于静脉闭合治疗后的偏心性压迫敷料,涉及止血材料技术领域,其技术方案要点是包括止血纱布,止血纱布包括织物、浸渍在织物内的止血药剂和杀菌消毒药剂;所述止血药剂是由以下成分按重量份制备而成:黄龙尾5‑8份、铁苋草8‑10份、富贵菜4‑7份、沙棘油5‑9份、依地酸钠3‑6份、三七2‑4份、景天三七1‑3份、芒硝2.5‑3.5份、大黄1.5‑2.5份、槐花1‑3份、仙鹤草3‑4份、艾叶3‑4份、蒲黄1‑3份;所述杀菌消毒药剂是由以下成分按重量份制备而成:桂皮9‑11份、青叶丹5‑9份、尾参3‑8份、白芷2‑5份。本发明解决了止血时间长且伤口容易感染的问题,达到了快速止血且杀菌消毒的效果。The invention discloses an eccentric compressive dressing for venous closure treatment, which relates to the technical field of hemostatic materials, and the main point of the technical solution is to include hemostatic gauze, and the hemostatic gauze includes fabric, a hemostatic agent and a sterilizing agent impregnated in the fabric; The hemostatic agent is prepared from the following ingredients in parts by weight: 5-8 parts of huanglongwei, 8-10 parts of amaranth, 4-7 parts of rich cabbage, 5-9 parts of seabuckthorn oil, 3-3 parts of edetate sodium 6 parts, Panax notoginseng 2‑4 parts, Sedum notoginseng 1‑3 parts, Glauber's salt 2.5‑3.5 parts, Rhubarb 1.5‑2.5 parts, Sophora japonica 1‑3 parts, Agrimony 3‑4 parts, Artemisia argyi 3‑4 parts 1-3 parts of Puhuang; the bactericidal disinfectant is prepared from the following components by weight: 9-11 parts of cassia bark, 5-9 parts of Aoba dan, 3-8 parts of ginseng, 2-5 parts of Angelica dahurica . The invention solves the problems of long hemostasis time and easy infection of the wound, and achieves the effects of fast hemostasis and sterilization.
Description
技术领域technical field
本发明涉及医用止血材料技术领域,更具体的说,它涉及一种用于静脉闭合治疗后的偏心性压迫敷料及其生产方法。The invention relates to the technical field of medical hemostatic materials, more specifically, it relates to an eccentric compressive dressing for vein closure treatment and a production method thereof.
背景技术Background technique
治疗静脉曲张时需要在腿部静脉曲张的血管上扎出出血口,然后将止血纱布覆盖在出血口上,再穿上静脉曲张袜,将止血纱布固定在出血口上使出血口愈合。When treating varicose veins, it is necessary to puncture the bleeding port on the blood vessels of the varicose veins in the leg, then cover the bleeding port with hemostatic gauze, put on varicose vein socks, and fix the hemostatic gauze on the bleeding port to heal the bleeding port.
现有技术中,可参考授权公告号为CN103800940B的中国发明专利文件,其公开了一种止血敷料及制备方法,包括如下步骤:称取矿物类止血颗粒、柔软剂、粘合剂、抑菌材料,促凝血材料和水;将矿物类止血颗粒、柔软剂、粘合剂加入水中混匀,煮沸,冷却,加入抑菌材料和促凝血材料混匀,得到止血剂悬液;将所述止血剂悬液固定粘附在支撑基质上,干燥,即得到一种止血敷料。In the prior art, you can refer to the Chinese invention patent document with the authorized announcement number CN103800940B, which discloses a hemostatic dressing and its preparation method, including the following steps: weighing mineral hemostatic particles, softener, adhesive, and antibacterial material , procoagulant material and water; mineral hemostatic granules, softener, and adhesive are added to water and mixed, boiled, cooled, added antibacterial material and procoagulant material and mixed to obtain hemostatic agent suspension; the hemostatic agent The suspension is fixedly adhered to the support matrix and dried to obtain a hemostatic dressing.
现有的这种止血敷料利用采用矿物类止血颗粒作为止血材料的一部分,矿物类颗粒在粘合剂的作用下粘合在支撑基质上,矿物类颗粒与伤口接触时,容易造成伤口感染,因此需要生产一种能够快速止血且能够杀菌消毒的用于静脉闭合治疗后的偏心性压迫敷料及其生产方法。The existing hemostatic dressing utilizes mineral hemostatic particles as part of the hemostatic material. The mineral particles are bonded to the support matrix under the action of the adhesive. When the mineral particles come into contact with the wound, it is easy to cause wound infection. Therefore, It is necessary to produce an eccentric compression dressing and a production method thereof that can quickly stop bleeding and can be sterilized for vein closure treatment.
发明内容Contents of the invention
针对现有技术存在的不足,本发明的目的在于提供一种用于静脉闭合治疗后的偏心性压迫敷料,其通过将织物放置在止血药剂和杀菌消毒药剂中浸渍,能够制备出快速止血且能够杀菌消毒的用于静脉闭合治疗后的偏心性压迫敷料。Aiming at the deficiencies in the prior art, the object of the present invention is to provide an eccentric compression dressing for venous closure treatment, which can prepare rapid hemostasis and can Sterilized eccentric compression dressing for post-venous closure therapy.
为实现上述目的,本发明提供了如下技术方案:一种用于静脉闭合治疗后的偏心性压迫敷料,包括止血纱布,止血纱布包括织物、浸渍在织物内的止血药剂和杀菌消毒药剂;所述止血药剂和所述杀菌消毒药剂的质量比为1.3-1.5:0.6-0.9;所述止血药剂是由以下成分按重量份制备而成:黄龙尾5-8份、铁苋草8-10份、富贵菜4-7份、沙棘油5-9份、依地酸钠3-6份、三七2-4份、景天三七1-3份、芒硝2.5-3.5份、大黄1.5-2.5份、槐花1-3份、仙鹤草3-4份、艾叶3-4份、蒲黄1-3份;所述杀菌消毒药剂是由以下成分按重量份制备而成:桂皮9-11份、青叶丹5-9份、尾参3-8份、白芷2-5份。In order to achieve the above object, the present invention provides the following technical solutions: an eccentric compression dressing for venous closure treatment, including hemostatic gauze, the hemostatic gauze includes fabric, hemostatic agent and sterilizing agent impregnated in the fabric; The mass ratio of the hemostatic agent to the bactericidal and disinfectant agent is 1.3-1.5:0.6-0.9; the hemostatic agent is prepared from the following ingredients in parts by weight: 5-8 parts of huanglongwei, 8-10 parts of amaranth, Fuguicai 4-7 parts, seabuckthorn oil 5-9 parts, edetate sodium 3-6 parts, Sanqi 2-4 parts, Sedum notoginseng 1-3 parts, Glauber's salt 2.5-3.5 parts, rhubarb 1.5-2.5 parts , 1-3 parts of Sophora japonica, 3-4 parts of Agrimony, 3-4 parts of Folium Artemisiae Argyi, 1-3 parts of Puhuang; the bactericidal disinfectant is prepared by the following components by weight: 9-11 parts of cassia bark, 5-9 parts of Qingye Dan, 3-8 parts of tail ginseng, and 2-5 parts of Angelica dahurica.
通过采用上述技术方案,黄龙尾中含有仙鹤草素、仙鹤草内酯、儿茶酚等,能够缩短血凝时间,增加血小板,促进血小板的生成并能够增加血钙,有较好的快速止血作用;铁苋草能够清热解毒,凉血止血;富贵菜的茎叶中含有大量的藻胶素,甘露醇,维生素B,磺,钾及多种氨基酸等营养元素,具有较好的止血的作用;沙棘油中的沙棘总黄酮能够降低高血脂,软化血管,并且能够清楚血管内壁沉积物,使出血口的沉积物清除干净;三七、景天三七能够使局部血管收缩,具有良好的止血镇痛的效果;将芒硝和大黄一起使用,可清热解毒,止血收敛,消肿止痛,使伤口快速收敛愈合;槐花含有多种化学成分,其中芸香甙及其甙元槲皮素能够保持毛细血管的正常抵抗力,减少血管通透性,可增加毛细血管的弹性,达到快速止血的血管;仙鹤草、艾叶和蒲黄都具有快速收敛止血,缩短血液凝固时间,增加血小板数量,抑制纤维蛋白溶酶的活性,止血作用较好;桂皮能够抑制多种致病真菌的滋长,能够杀菌消毒;青叶丹具有清热解毒、消炎杀菌等功效,能够防止出血口发炎,抑制细菌滋长;尾参和白芷能够解热镇痛、抑制真菌滋长;利用多种具有缩短血凝时间的黄龙骨、铁苋草、富贵菜等,增加血小板,快速止血的原材料,能够使出血口快速止血,且能收敛出血口,防止再次出血;利用桂皮、青叶丹、尾参和白芷,能够抑制细菌滋长,防止出血口感染,促进出血口快速愈合。By adopting the above-mentioned technical scheme, Huanglongwei contains agrimonin, agrilide, catechol, etc., which can shorten blood coagulation time, increase platelets, promote platelet production and increase blood calcium, and have a better rapid hemostasis effect ;Amaranth can clear away heat and detoxify, cool blood and stop bleeding; the stems and leaves of Fuguicai contain a lot of nutrients such as alginate, mannitol, vitamin B, sulphur, potassium and various amino acids, which have a good hemostatic effect; The total flavonoids of seabuckthorn in seabuckthorn oil can reduce hyperlipidemia, soften blood vessels, and clear the deposits on the inner wall of blood vessels, so that the deposits at the bleeding port can be removed; Panax notoginseng and sedum notoginseng can shrink local blood vessels, and have a good hemostatic effect. Pain effect; using Glauber's salt and rhubarb together can clear away heat and detoxify, stop bleeding and astringe, reduce swelling and relieve pain, and make wounds heal quickly; Sophora japonica contains a variety of chemical components, among which rutin and its aglycone quercetin can maintain blood capillaries The normal resistance of blood vessels can reduce the permeability of blood vessels, increase the elasticity of capillaries, and achieve rapid hemostasis of blood vessels; Agrimony, Artemisia argyi and Puhuang all have rapid convergence and hemostasis, shorten blood coagulation time, increase platelet count, and inhibit fibrinolysis. Enzyme activity, good hemostatic effect; cinnamon can inhibit the growth of a variety of pathogenic fungi, and can sterilize; Qingye Dan has the effects of clearing away heat and detoxification, anti-inflammatory and sterilizing, can prevent inflammation of the bleeding port, and inhibit bacterial growth; ginseng and Angelica dahurica Antipyretic, analgesic, and fungal growth inhibition; using a variety of yellow keel, iron amaranth, rich vegetables, etc., which can shorten the blood clotting time, increase platelets, and quickly stop bleeding raw materials, which can quickly stop bleeding at the bleeding site and can restrain the bleeding site , to prevent re-bleeding; using cinnamon bark, Qingyedan, tail ginseng and Angelica dahurica can inhibit the growth of bacteria, prevent infection of the bleeding port, and promote rapid healing of the bleeding port.
本发明进一步设置为:所述止血纱布中还包括祛疤剂,所述祛疤剂与所述止血药剂的质量比为0.2-0.4:1.3-1.5,所述祛疤剂是由以下成分按重量份制备而成:芦荟汁4-9份、新鲜仙人掌汁2-6份、蜂蜜1-4份。The present invention is further configured as follows: the hemostatic gauze also includes a scar-removing agent, the mass ratio of the scar-removing agent to the hemostatic agent is 0.2-0.4:1.3-1.5, and the scar-removing agent is composed of the following components by weight: Prepared in 3 parts: 4-9 parts of aloe vera juice, 2-6 parts of fresh cactus juice, 1-4 parts of honey.
通过采用上述技术方案,芦荟汁富含芦荟大黄素与安特拉归农综合体,敷在出血口上能够促进出血口愈合,且使出血口处不留疤;仙人掌汁和蜂蜜能够灭菌消毒、减少疼痛、促进伤口愈合、防止感染、防止出血口留疤;在止血纱布中加入祛疤剂,能够促进伤口愈合,促进生肌生长,防止出血口留疤。By adopting the above-mentioned technical scheme, aloe vera juice is rich in aloe-emodin and Antraguinong complex, which can promote the healing of the bleeding port and leave no scars at the bleeding port when applied on the bleeding port; cactus juice and honey can sterilize, disinfect, Reduce pain, promote wound healing, prevent infection, and prevent bleeding from scarring; adding scar remover to the hemostatic gauze can promote wound healing, promote muscle growth, and prevent bleeding from scarring.
本发明进一步设置为:所述止血纱布中还包括镇痛剂,所述镇痛剂与所述止血药剂的质量比为0.1-0.2:1.3-1.5,所述镇痛剂包括维生素B12 6-10份、冰片3-6份、乳香4-7份、苏木1-4份。The present invention is further configured as follows: the hemostatic gauze also includes an analgesic, the mass ratio of the analgesic to the hemostatic agent is 0.1-0.2:1.3-1.5, and the analgesic includes vitamin B12 6-10 3-6 parts of borneol, 4-7 parts of frankincense, 1-4 parts of sumac.
通过采用上述技术方案,冰片能够清热止痛、消肿、防腐生肌、促进出血口收敛愈合;乳香能够消肿生肌、止痛、收敛伤口;苏木能够消肿、止痛;在止血纱布中添加镇痛剂,能够减轻患者的疼痛,促进伤口的愈合。By adopting the above technical scheme, borneol can clear away heat and relieve pain, reduce swelling, antiseptic and promote muscle growth, and promote the convergence and healing of bleeding ports; frankincense can reduce swelling and muscle growth, relieve pain, and astringe wounds; Analgesic, which can relieve the patient's pain and promote wound healing.
本发明进一步设置为:所述止血纱布中还包括愈合剂,所述愈合剂与所述止血药剂的质量比为0.3-0.5:1.3-1.5,所述愈合剂是由以下成分按重量份制备而成:维生素B24-8份、维生素B6 5-10份、维生素C 4-9份。The present invention is further set as follows: the hemostatic gauze also includes a healing agent, the mass ratio of the healing agent to the hemostatic agent is 0.3-0.5:1.3-1.5, and the healing agent is prepared from the following ingredients in parts by weight Composition: 4-8 parts of vitamin B2, 5-10 parts of vitamin B6, 4-9 parts of vitamin C.
通过采用上述技术方案,维生素B2能够消肿和促进细胞再生,促进皮肤的生长,和维生素B6公用,效果更好,维生素B6能够保护血管内皮细胞,维生素C能维持免疫功能,保持血管完整,能够促进出血口愈合。By adopting the above technical scheme, vitamin B2 can reduce swelling, promote cell regeneration, and promote skin growth. It is shared with vitamin B6 and has a better effect. Vitamin B6 can protect vascular endothelial cells, and vitamin C can maintain immune function and keep blood vessels intact. Promotes healing of bleeding wounds.
本发明进一步设置为:还包括包裹在止血纱布外用于防止止血纱布散开的网罩。The present invention is further configured to: further include a net cover wrapped outside the hemostatic gauze for preventing the hemostatic gauze from spreading.
通过采用上述技术方案,将止血纱布包裹在网罩内,可使止血纱布较为集中的敷在出血口处,且不会散开,便于止血纱布对出血口进行快速止血。By adopting the above-mentioned technical scheme, the hemostatic gauze is wrapped in the net cover, so that the hemostatic gauze can be applied more concentratedly on the bleeding port without spreading, so that the hemostatic gauze can quickly stop bleeding from the bleeding port.
本发明进一步设置为:所述网罩与所述止血纱布接触的一侧上设置有用于将网罩粘附在止血纱布上的粘胶层。The present invention is further provided that: the side of the mesh cover in contact with the hemostatic gauze is provided with an adhesive layer for adhering the mesh cover to the hemostatic gauze.
通过采用上述技术方案,设置在网罩靠近止血纱布一侧上的粘胶层,能够便于网罩将止血纱布紧密的包裹在网罩内,防止止血纱布的使用过程中散开。By adopting the above technical solution, the viscose layer arranged on the side of the net cover close to the hemostatic gauze can facilitate the net cover to tightly wrap the hemostatic gauze in the net cover, preventing the hemostatic gauze from being scattered during use.
本发明进一步设置为:所述粘胶层是由以下成分按质量份制备而成:荨麻根4-6份、白芨5-8份、蒲公英2-3份、连翘3-4份、马勃1-3份。The present invention is further set as follows: the adhesive layer is prepared from the following components in parts by mass: 4-6 parts of nettle root, 5-8 parts of Bletilla striata, 2-3 parts of dandelion, 3-4 parts of forsythia, Bo 1-3 parts.
通过采用上述技术方案,蒲公英、连翘能够清热解毒、消炎止痛;马勃具有明显的止血效果,且对致病真菌具有抑制作用;白芨具有较好的收敛止血、消肿生肌的功效,还可以抑制真菌滋长;荨麻根具有止痛的作用,且荨麻根和白芨都具有一定的黏性,能够将网罩粘附在止血纱布上,防止网罩与止血纱布分离,影响止血纱布的使用。By adopting the above technical scheme, dandelion and forsythia can clear away heat and detoxify, reduce inflammation and relieve pain; puffball has obvious hemostatic effect, and has inhibitory effect on pathogenic fungi; It can inhibit the growth of fungi; nettle root has analgesic effect, and both nettle root and bletilla striata have certain viscosity, which can adhere the net cover to the hemostatic gauze, prevent the net cover from separating from the hemostatic gauze, and affect the use of the hemostatic gauze .
本发明进一步设置为:所述网罩由弹性材料制成。The present invention is further provided that: the net cover is made of elastic material.
通过采用上述技术方案,由弹性材料制成的网罩具有一定的弹性,能够装入不同量的止血纱布,可根据止血口的大小装入止血纱布,避免止血纱布的浪费,能够节约止血纱布的用量。By adopting the above technical scheme, the net cover made of elastic material has a certain degree of elasticity, and can be loaded with different amounts of hemostatic gauze, and can be loaded with hemostatic gauze according to the size of the hemostatic opening, so as to avoid the waste of hemostatic gauze and save the cost of hemostatic gauze Dosage.
针对现有技术存在的不足,本发明的另一个目的在于提供一种用于静脉闭合治疗后的偏心性压迫敷料的生产方法,利用该生产方法加工出的用于静脉闭合治疗后的偏心性压迫敷料能够快速止血和杀菌消毒。In view of the deficiencies in the prior art, another object of the present invention is to provide a production method for eccentric compressive dressings after venous closure therapy, and the eccentric compressive dressings processed by this production method are used for venous occlusive therapy. The dressing can quickly stop bleeding and sterilize.
为实现上述目的,本发明提供了如下技术方案:包括以下步骤:To achieve the above object, the present invention provides the following technical solutions: comprising the following steps:
(1)取总重量是5-8份黄龙尾、8-10份铁苋草、4-7份富贵菜、5-9份沙棘油和3-6份依地酸钠总重量3.5-4.7倍的纯净水并煮沸,依次向沸水中加入5-8份黄龙尾、8-10份铁苋草、4-7份富贵菜、5-9份沙棘油和3-6份依地酸钠,煎煮两次,每次煎煮1-2小时,合并煎煮后的煎液,并用微孔滤膜过滤;(1) The total weight is 3.5-4.7 times the total weight of 5-8 parts of Huanglongwei, 8-10 parts of Amaranth, 4-7 parts of Fuguicai, 5-9 parts of seabuckthorn oil and 3-6 parts of edetate sodium Add 5-8 parts of yellow dragon tail, 8-10 parts of iron amaranth, 4-7 parts of Fuguicai, 5-9 parts of seabuckthorn oil and 3-6 parts of sodium edetate to the boiling water in turn, fry Boil twice, each time for 1-2 hours, combine the decoction after decoction, and filter with a microporous membrane;
(2)向步骤(1)中所得滤液中加入2-4份三七、1-3份景天三七、2.5-3.5份芒硝、1.5-2.5份大黄、1-3份槐花、3-4份仙鹤草、3-4份艾叶、1-3份蒲黄,煎煮一次,煎煮时间为2-3小时,用微孔滤膜过滤,将滤液浓缩成相对密度为0.46的药液,备用;(2) Add 2-4 parts of Panax notoginseng, 1-3 parts of Sedum notoginseng, 2.5-3.5 parts of Glauber's salt, 1.5-2.5 parts of rhubarb, 1-3 parts of Sophora japonica, 3- 4 parts of agrimony, 3-4 parts of mugwort leaves, 1-3 parts of Puhuang, decoct once for 2-3 hours, filter with a microporous membrane, concentrate the filtrate into a liquid medicine with a relative density of 0.46, spare;
(3)取总质量是9-11份桂皮、2-5份白芷、3-8份尾参总质量4.6-5.8倍的纯净水,向煮沸的水中加入9-11份桂皮、2-5份白芷、3-8份尾参,并煮沸,再加入5-9份青叶丹,煎煮三次,每次煎煮2.5-3小时,合并煎煮后的煎液,并用微孔滤膜过滤,将滤液浓缩成相对密度为0.43的药液,备用;(3) Take 9-11 parts of cinnamon, 2-5 parts of Angelica dahurica, 3-8 parts of pure water with 4.6-5.8 times the total mass of ginseng, add 9-11 parts of cinnamon, 2-5 parts of ginseng to the boiling water Angelica dahurica, 3-8 parts of tail ginseng, and boiled, then add 5-9 parts of Qingyedan, decoct three times, each decocting for 2.5-3 hours, combine the decocted decoction, and filter with a microporous membrane, Concentrate the filtrate into a medicinal solution with a relative density of 0.43 for subsequent use;
(4)取4-9份芦荟汁,加热到80-110℃,在300-500转/min的转速下,向芦荟汁中缓慢加入2-6份仙人掌汁,搅拌均匀后升温至120-130℃,将转速提高至600-800转/min,向混合液中加入1-4份蜂蜜搅拌均匀,备用;(4) Take 4-9 portions of aloe vera juice, heat it to 80-110°C, and slowly add 2-6 portions of cactus juice to the aloe vera juice at a speed of 300-500 rpm, stir evenly and heat up to 120-130°C ℃, increase the rotation speed to 600-800 rpm, add 1-4 parts of honey to the mixture, stir evenly, and set aside;
(5)取3-6份冰片、4-7份乳香、1-4份苏木和6-10份维生素B12进行球磨粉碎,球料比为1.8:1,球磨时间为20-60min,备用(5) Take 3-6 parts of borneol, 4-7 parts of frankincense, 1-4 parts of sumac and 6-10 parts of vitamin B12 for ball milling, the ball-to-material ratio is 1.8:1, and the ball milling time is 20-60min.
(6)取4-8份维生素B2、5-10份维生素B6和4-9份维生素C进行球磨粉碎,球料比为1.6:1,球磨时间为30-50min,备用;(6) Take 4-8 parts of vitamin B2, 5-10 parts of vitamin B6 and 4-9 parts of vitamin C for ball milling and pulverization, the ball-to-material ratio is 1.6:1, and the ball milling time is 30-50min, and set aside;
(7)将步骤(2)所得的液体加热至100-120℃,在转速为200-300转/min下,将步骤(3)和步骤(4)所得的液体、以及步骤(5)和步骤(6)中所得的混合粉依次加入步骤(2)所得的液体中,保温20-30min后降至常温;(7) Heat the liquid obtained in step (2) to 100-120 ° C, and at a speed of 200-300 rpm, the liquid obtained in step (3) and step (4), and the liquid obtained in step (5) and step The mixed powder of gained in (6) is added in the liquid of step (2) gained successively, be down to normal temperature after being incubated 20-30min;
(8)将织物按浴比为1:30-50放置在步骤(7)所得的混合液中浸渍40-60min,将浸渍后的织物取出,脱水5-8min;(8) placing the fabric in the mixed solution obtained in step (7) for 40-60 min at a bath ratio of 1:30-50, and then taking out the soaked fabric and dehydrating for 5-8 min;
(9)将步骤(8)中脱水后的织物放置在紫外线下进行消毒,消毒时间20-30min;(9) placing the dehydrated fabric in step (8) under ultraviolet light for disinfection, the disinfection time is 20-30min;
(10)将织物上涂抹粘胶层,将网罩套在织物上即制得用于静脉闭合治疗后的偏心性压迫敷料。(10) Smear the viscose layer on the fabric, and put the mesh cover on the fabric to obtain an eccentric compressive dressing for venous closure treatment.
通过采用上述技术方案,将黄龙尾、铁苋草、富贵菜、沙棘油和依地酸钠先进行煎煮,且煎煮两次,能够将各原料内的提取物完全提取出来;在向步骤(1)中的混合物中加入三七等,再次煎煮,可使黄龙尾和三七等的提取物充分混合均为,且提取完全;因为桂皮、白芷和尾参较为干枯,难以提取,先将桂皮、白芷和尾参在水中煮沸,能够便于提取桂皮、白芷和尾参中的提取物;将芦荟汁加热能够起到杀菌消毒的作用,在搅拌下加入仙人掌汁,能够便于芦荟汁和仙人掌汁混合均匀,因为蜂蜜较为粘稠,将温度升高,能够便于蜂蜜软化,提高转速,能够便于将蜂蜜与芦荟汁和仙人掌汁的混合物混合均匀;因为冰片具有挥发性,易升华;乳香预热容易软化;维生素B12预热会有一定的破坏程度,所以采用球磨粉碎,能够将冰片、乳香等研磨较细;维生素B2加热时是稳定的且维生素B6是不耐高温的,所以采用球磨粉碎形式磨碎;最后将所得的备用原料混合均匀,将织物浸渍完全后脱水,再进行紫外线杀菌消毒,最后将止血纱布上罩上网罩,制作出快速止血且能够杀菌消毒的用于静脉闭合治疗后的偏心性压迫敷料。By adopting the above-mentioned technical scheme, decocting the yellow dragon tail, iron amaranth, rich cabbage, seabuckthorn oil and sodium edetate first, and decocting twice, the extracts in each raw material can be completely extracted; in the step Add notoginseng, etc. to the mixture in (1), and decoct again, so that the extracts of Huanglongwei and notoginseng can be fully mixed and extracted completely; Boiling cinnamon bark, angelica dahurica and ginseng in water can facilitate the extraction of cinnamon bark, angelica and ginseng; heating aloe juice can play a role in sterilization, and adding cactus juice under stirring can facilitate the extraction of aloe juice and cactus Mix the juice evenly, because the honey is relatively viscous, increasing the temperature can facilitate the softening of the honey, increase the speed, and facilitate the mixture of honey, aloe vera juice and cactus juice; because the borneol is volatile and easy to sublime; the frankincense is preheated It is easy to soften; vitamin B12 will be damaged by preheating to a certain extent, so ball milling is used to grind borneol, frankincense, etc.; vitamin B2 is stable when heated and vitamin B6 is not resistant to high temperatures, so ball milling is used Grinding; finally, mix the obtained spare raw materials evenly, dehydrate the fabric after soaking completely, and then sterilize with ultraviolet light, and finally cover the hemostatic gauze with a net cover to make a quick hemostatic and sterilizable tissue for venous closure treatment Eccentric compression dressings.
本发明进一步设置为:所述步骤(9)中紫外线是指C波紫外线,照射波长为250-270nm。The present invention is further set as: the ultraviolet rays in the step (9) refer to C-wave ultraviolet rays, and the irradiation wavelength is 250-270nm.
通过采用上述技术方案,C波紫外线能够造成生长性细胞死忙或再生性细胞死亡,达到杀菌消毒的作用,在250-270nm的波长下对织物进行杀菌,能够杀菌更彻底。By adopting the above-mentioned technical scheme, C-wave ultraviolet rays can cause the death of growth cells or regenerative cells to achieve the effect of sterilization and disinfection. Sterilization of fabrics at a wavelength of 250-270nm can achieve more thorough sterilization.
综上所述,本发明相比于现有技术具有以下有益效果:In summary, compared with the prior art, the present invention has the following beneficial effects:
(1)本发明通过将织物放置在止血药剂和杀菌消毒药剂中浸渍,能够制备出快速止血且杀菌消毒的用于静脉闭合治疗后的偏心性压迫敷料;(1) The present invention can prepare an eccentric compression dressing for rapid hemostasis and sterilization after venous closure treatment by placing the fabric in the hemostatic agent and sterilizing agent for immersion;
(2)本发明通过在用于静脉闭合治疗后的偏心性压迫敷料中添加祛疤剂,能够使出血口不留疤痕;(2) The present invention can make the bleeding port leave no scar by adding the scar removing agent in the eccentric compressive dressing after the venous closure treatment;
(3)本发明通过在用于静脉闭合治疗后的偏心性压迫敷料中添加镇痛剂,能够减轻患者的疼痛;(3) The present invention can alleviate the patient's pain by adding an analgesic to the eccentric compression dressing used for venous closure therapy;
(4)本发明通过在用于静脉闭合治疗后的偏心性压迫敷料中添加愈合剂,能够促进出血口愈合,缩短愈合时间;(4) The present invention can promote the healing of the hemorrhage and shorten the healing time by adding a healing agent in the eccentric compression dressing used for venous closure treatment;
(5)本发明通过制备在止血纱布上罩上网罩,用网罩将止血纱布包裹住,防止止血纱布散开,使止血纱布较为集中的按压在出血口处。(5) The present invention covers the hemostatic gauze with a net cover on the hemostatic gauze, wraps the hemostatic gauze with the net cover, prevents the hemostatic gauze from spreading, and makes the hemostatic gauze more concentratedly pressed on the bleeding port.
具体实施方式Detailed ways
实施例1:一种用于静脉闭合治疗后的偏心性压迫敷料,包括止血纱布和包裹在止血纱布外用于防止止血纱布散开的网罩;网罩由弹性材料制成;网罩与止血纱布接触的一侧上设置有用于将止血纱布粘附在止血纱布上的粘胶层;粘胶层是由以下成分按质量份而成:4份荨麻根、5份白芨、2份蒲公英、3份连翘和1份马勃。Embodiment 1: An eccentric compression dressing for venous closure treatment, comprising hemostatic gauze and a mesh cover wrapped in the hemostatic gauze to prevent the hemostatic gauze from spreading; the mesh cover is made of elastic material; the mesh cover and the hemostatic gauze A viscose layer for adhering the hemostatic gauze to the hemostatic gauze is arranged on the contacting side; the viscose layer is made of the following components in parts by mass: 4 parts of nettle root, 5 parts of bletilla striata, 2 parts of dandelion, 3 parts of dandelion 1 part forsythia and 1 part puffball.
其中止血纱布包括织物、浸渍在织物上的止血药剂、杀菌消毒药剂、祛疤剂、镇痛剂和愈合剂;其中止血药剂、杀菌消毒药剂、祛疤剂、镇痛剂和愈合剂的质量比是1.3:0.6:0.2:0.1:0.3;Wherein the hemostatic gauze comprises fabric, the hemostatic agent impregnated on the fabric, bactericidal disinfectant, scar remover, analgesic and healing agent; wherein the mass ratio of hemostatic agent, bactericidal disinfectant, scar remover, analgesic and healing agent is 1.3:0.6:0.2:0.1:0.3;
止血药剂是由以下成分按质量份制备而成:5份黄龙尾、8份铁苋草、4份富贵菜、5份沙棘油、3份依地酸钠、2份三七;1份景天三七;2.5份芒硝;1.5份大黄、1份槐花、3份仙鹤草、3份艾叶和1份蒲黄;杀菌消毒药剂是由以下成分按质量份制备而成:9份桂皮、5份青叶丹、3份尾参和2份白芷;祛疤剂是由以下成分按质量份制备而成:4份芦荟汁、2份新鲜仙人掌汁和1份蜂蜜;镇痛剂是由以下成分按质量份制备而成:6份维生素B12、3份冰片、4份乳香和1份苏木;愈合剂是由以下成分按质量份制备而成:4份维生素B2、5份维生素B6和4份维生素C。The hemostatic agent is prepared from the following ingredients in parts by mass: 5 parts of huanglongwei, 8 parts of amaranth, 4 parts of rich cabbage, 5 parts of seabuckthorn oil, 3 parts of edetate sodium, 2 parts of Panax notoginseng; 1 part of sedum sedum Panax notoginseng; 2.5 parts of Glauber's salt; 1.5 parts of rhubarb, 1 part of Sophora japonica, 3 parts of Agrimony, 3 parts of Artemisia argyi and 1 part of Puhuang; the sterilizing agent is prepared from the following ingredients in parts by mass: 9 parts of cinnamon, 5 parts Qingye Dan, 3 parts of ginseng and 2 parts of Angelica dahurica; the scar remover is prepared from the following ingredients by mass parts: 4 parts of aloe vera juice, 2 parts of fresh cactus juice and 1 part of honey; the analgesic is made of the following ingredients by weight Prepared in parts by mass: 6 parts of vitamin B12, 3 parts of borneol, 4 parts of frankincense and 1 part of sumac; the healing agent is prepared in parts by mass of the following ingredients: 4 parts of vitamin B2, 5 parts of vitamin B6 and 4 parts of vitamin c.
该用于静脉闭合治疗后的偏心性压迫敷料的生产方法包括以下步骤:The production method of the eccentric compression dressing for venous closure therapy comprises the following steps:
(1)取总重量是5份黄龙尾、8份铁苋草、4份富贵菜、5份沙棘油和3份依地酸钠总重量3.5倍的纯净水并煮沸,依次向沸水中加入5份黄龙尾、8份铁苋草、4份富贵菜、5份沙棘油和3份依地酸钠,煎煮两次,每次煎煮1小时,合并煎煮后的煎液,并用微孔滤膜过滤;(1) Take pure water with a total weight of 5 parts of Huanglongwei, 8 parts of Amaranth, 4 parts of Fuguicai, 5 parts of seabuckthorn oil and 3 parts of edetate sodium 3.5 times the total weight and boil it, and add 5 parts to the boiling water in turn. 1 part of yellow dragon tail, 8 parts of iron amaranth, 4 parts of Fuguicai, 5 parts of seabuckthorn oil and 3 parts of edetate sodium, decoct twice, each decoction for 1 hour, combine the decoction after decoction, and use microporous Membrane filtration;
(2)向步骤(1)中所得滤液中加入2份三七、1份景天三七、2.5份芒硝、1.5份大黄、1份槐花、3份仙鹤草、3份艾叶、1份蒲黄,煎煮一次,煎煮时间为2小时,用微孔滤膜过滤,将滤液浓缩成相对密度为0.46的药液,备用;(2) Add 2 parts of Panax notoginseng, 1 part of Sedum notoginseng, 2.5 parts of Glauber's salt, 1.5 parts of rhubarb, 1 part of Sophora japonica, 3 parts of Agrimony, 3 parts of Artemisia argyi, 1 part of cattail in the filtrate obtained in step (1) yellow, decocted once, the decocting time is 2 hours, filtered with a microporous membrane, and the filtrate was concentrated into a medicinal liquid with a relative density of 0.46, and set aside;
(3)取总质量是9份桂皮、2份白芷、3份尾参总质量4.6倍的纯净水,向煮沸的水中加入9份桂皮、2份白芷、3份尾参,并煮沸,再加入5份青叶丹,煎煮三次,每次煎煮2.5小时,合并煎煮后的煎液,并用微孔滤膜过滤,将滤液浓缩成相对密度为0.43的药液,备用;(3) Take 9 parts of cinnamon, 2 parts of Angelica dahurica, and 3 parts of ginseng in pure water with a total mass of 4.6 times, add 9 parts of cinnamon, 2 parts of Angelica dahurica, and 3 parts of ginseng into the boiling water, and boil it, then add 5 parts of Qingye Dan were decocted three times, each time decocted for 2.5 hours, combined the decocted decoction, and filtered with a microporous membrane, and the filtrate was concentrated into a medicinal solution with a relative density of 0.43 for subsequent use;
(4)取4份芦荟汁,加热到80℃,在300转/min的转速下,向芦荟汁中缓慢加入2份仙人掌汁,搅拌均匀后升温至120℃,将转速提高至600转/min,向混合液中加入1份蜂蜜搅拌均匀,备用;(4) Take 4 parts of aloe vera juice, heat it to 80°C, slowly add 2 parts of cactus juice to the aloe vera juice at a speed of 300 rpm, stir evenly, heat up to 120°C, and increase the speed to 600 rpm , add 1 part of honey to the mixture, stir evenly, set aside;
(5)取3份冰片、4份乳香、1份苏木和6份维生素B12进行球磨粉碎,球料比为1.8:1,球磨时间为20min,备用;(5) Take 3 parts of borneol, 4 parts of frankincense, 1 part of sumac and 6 parts of vitamin B12 for ball milling, the ball-to-material ratio is 1.8:1, the ball milling time is 20 minutes, and set aside;
(6)取4份维生素B2、5份维生素B6和4份维生素C进行球磨粉碎,球料比为1.6:1,球磨时间为30min,备用;(6) Take 4 parts of vitamin B2, 5 parts of vitamin B6 and 4 parts of vitamin C and carry out ball milling, the ball-to-material ratio is 1.6:1, the ball milling time is 30min, and set aside;
(7)将步骤(2)所得的液体加热至100℃,在转速为200转/min下,将步骤(3)和步骤(4)所得的液体、以及步骤(5)和步骤(6)中所得的混合粉依次加入步骤(2)所得的液体中,保温20min后降至常温;(7) Heat the liquid obtained in step (2) to 100 ° C, and at a speed of 200 rpm, the liquid obtained in step (3) and step (4), and the liquid obtained in step (5) and step (6) The mixed powder of gained is added in the liquid of step (2) gained successively, is down to normal temperature after the insulation 20min;
(8)将织物按浴比为1:30放置在步骤(7)所得的混合液中浸渍40min,将浸渍后的织物取出,脱水5min;(8) placing the fabric in the mixed solution obtained in step (7) for 40 minutes at a bath ratio of 1:30, and soaking for 40 minutes, taking out the soaked fabric, and dehydrating for 5 minutes;
(9)将步骤(8)中脱水后的织物放置在C波紫外线下进行消毒,照射波长为250nm,消毒时间20min;(9) Place the dehydrated fabric in step (8) under C-wave ultraviolet light for disinfection, the irradiation wavelength is 250nm, and the disinfection time is 20min;
(10)将织物上涂抹粘胶层,将网罩套在织物上即制得用于静脉闭合治疗后的偏心性压迫敷料。(10) Smear the viscose layer on the fabric, and put the mesh cover on the fabric to obtain an eccentric compressive dressing for venous closure treatment.
实施例2:一种用于静脉闭合治疗后的偏心性压迫敷料,,包括止血纱布和包裹在止血纱布外用于防止止血纱布散开的网罩;网罩由弹性材料制成;网罩与止血纱布接触的一侧上设置有用于将止血纱布粘附在止血纱布上的粘胶层;粘胶层是由以下成分按质量份而成:5份荨麻根、6.5份白芨、2.5份蒲公英、3.5份连翘和2份马勃。Embodiment 2: An eccentric compression dressing for venous closure treatment, comprising hemostatic gauze and a mesh cover wrapped outside the hemostatic gauze to prevent the hemostatic gauze from spreading; the mesh cover is made of elastic material; the mesh cover and hemostatic A viscose layer for adhering the hemostatic gauze to the hemostatic gauze is arranged on the side where the gauze contacts; 3.5 parts forsythia and 2 parts puffball.
其中止血纱布包括织物、浸渍在织物上的止血药剂、杀菌消毒药剂、祛疤剂、镇痛剂和愈合剂;其中止血药剂、杀菌消毒药剂、祛疤剂、镇痛剂和愈合剂的质量比是1.4:0.75:0.3:0.15:0.4;Wherein the hemostatic gauze comprises fabric, the hemostatic agent impregnated on the fabric, bactericidal disinfectant, scar remover, analgesic and healing agent; wherein the mass ratio of hemostatic agent, bactericidal disinfectant, scar remover, analgesic and healing agent is 1.4:0.75:0.3:0.15:0.4;
止血药剂是由以下成分按质量份制备而成:6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油、4.5份依地酸钠、3份三七、2份景天三七、3份芒硝、2份大黄、2份槐花、3.5份仙鹤草、3.5份艾叶和2份蒲黄;杀菌消毒药剂是由以下成分按质量份制备而成:10份桂皮、7份青叶丹、5.5份尾参和3.5份白芷;祛疤剂是由以下成分按质量份制备而成:6.5份芦荟汁、4份新鲜仙人掌汁和2.5份蜂蜜;镇痛剂是由以下成分按质量份制备而成:8份维生素B12、4.5份冰片、5.5份乳香和2.5份苏木;愈合剂是由以下成分按质量份制备而成:6份维生素B2、7.5份维生素B6和6.5份维生素C。The hemostatic agent is prepared from the following ingredients in parts by mass: 6.5 parts of huanglongwei, 9 parts of iron amaranth, 5.5 parts of rich cabbage, 7 parts of seabuckthorn oil, 4.5 parts of sodium edetate, 3 parts of Panax notoginseng, 2 parts of sedum sedum Panax notoginseng, 3 parts of Glauber's salt, 2 parts of rhubarb, 2 parts of Sophora japonica, 3.5 parts of Agrimony, 3.5 parts of Artemisia argyi and 2 parts of Puhuang; the sterilizing and disinfecting agent is prepared from the following ingredients by mass: 10 parts of cinnamon, 7 parts Qingye Dan, 5.5 parts of ginseng and 3.5 parts of Angelica dahurica; the scar remover is prepared from the following components by mass parts: 6.5 parts of aloe vera juice, 4 parts of fresh cactus juice and 2.5 parts of honey; the analgesic is made of the following components by weight Prepared in parts by mass: 8 parts of vitamin B12, 4.5 parts of borneol, 5.5 parts of frankincense and 2.5 parts of sumac; the healing agent is prepared by parts by mass of the following ingredients: 6 parts of vitamin B2, 7.5 parts of vitamin B6 and 6.5 parts of vitamin c.
该用于静脉闭合治疗后的偏心性压迫敷料的生产方法包括以下步骤:The production method of the eccentric compression dressing for venous closure therapy comprises the following steps:
(1)取总重量是6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油和4.5份依地酸钠总重量4.1倍的纯净水并煮沸,依次向沸水中加入6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油和4.5份依地酸钠,煎煮两次,每次煎煮1。5小时,合并煎煮后的煎液,并用微孔滤膜过滤;(1) Take 6.5 parts of Huanglongwei, 9 parts of Amaranth, 5.5 parts of Fuguicai, 7 parts of seabuckthorn oil and 4.5 parts of pure water 4.1 times the total weight of sodium edetate and boil it, and add 6.5 parts to the boiling water in turn. 5 parts of Huanglongwei, 9 parts of iron amaranth, 5.5 parts of Fuguicai, 7 parts of seabuckthorn oil and 4.5 parts of edetate sodium, decocted twice, each time for 1.5 hours, combined the decocted decoction, and used Microporous membrane filtration;
(2)向步骤(1)中所得滤液中加入3份三七、2份景天三七、3份芒硝、2份大黄、2份槐花、3.5份仙鹤草、3.5份艾叶和2份蒲黄,煎煮一次,煎煮时间为2.5小时,用微孔滤膜过滤,将滤液浓缩成相对密度为0.46的药液,备用;(2) Add 3 parts of Panax notoginseng, 2 parts of Sedum notoginseng, 3 parts of Glauber's salt, 2 parts of rhubarb, 2 parts of Sophora japonica, 3.5 parts of Agrimony, 3.5 parts of Artemisia argyi and 2 parts of cattail in the filtrate obtained in step (1) Yellow, decocted once, the decoction time is 2.5 hours, filtered with a microporous membrane, and the filtrate is concentrated into a medicinal liquid with a relative density of 0.46, and set aside;
(3)取总质量是10份桂皮、3.5份白芷和5.5份尾参总质量5.2倍的纯净水,向煮沸的水中加入10份桂皮、3.5份白芷和5.5份尾参,并煮沸,再加入7份青叶丹,煎煮三次,每次煎煮2.7小时,合并煎煮后的煎液,并用微孔滤膜过滤,将滤液浓缩成相对密度为0.43的药液,备用;(3) Take the pure water whose total mass is 10 parts of cinnamon, 3.5 parts of Angelica dahurica and 5.5 parts of tail ginseng 5.2 times the total mass, add 10 parts of cinnamon, 3.5 parts of Angelica dahurica and 5.5 parts of tail ginseng to the boiling water, and boil it, then add 7 parts of Qingye Dan were decocted three times, each decocting for 2.7 hours, the decoction after merging was decocted, and filtered with a microporous membrane, and the filtrate was concentrated into a medicinal solution with a relative density of 0.43 for subsequent use;
(4)取6.5份芦荟汁,加热到95℃,在400转/min的转速下,向芦荟汁中缓慢加入4份仙人掌汁,搅拌均匀后升温至125℃,将转速提高至700转/min,向混合液中加入2.5份蜂蜜搅拌均匀,备用;(4) Take 6.5 parts of aloe vera juice, heat it to 95°C, slowly add 4 parts of cactus juice to the aloe vera juice at a speed of 400 rpm, stir evenly, heat up to 125°C, and increase the speed to 700 rpm , add 2.5 parts of honey to the mixture, stir evenly, set aside;
(5)取4.5份冰片、5.5份乳香、2.5份苏木和8份维生素B12进行球磨粉碎,球料比为1.8:1,球磨时间为40min,备用;(5) Take 4.5 parts of borneol, 5.5 parts of frankincense, 2.5 parts of hematoxylin and 8 parts of vitamin B12 for ball milling and pulverization, the ball-to-material ratio is 1.8:1, and the ball milling time is 40 minutes, and set aside;
(6)取6份维生素B2、7.5份维生素B6和6.5份维生素C进行球磨粉碎,球料比为1.6:1,球磨时间为40min,备用;(6) Take 6 parts of vitamin B2, 7.5 parts of vitamin B6 and 6.5 parts of vitamin C and carry out ball milling, the ball-to-material ratio is 1.6:1, and the ball milling time is 40min, and set aside;
(7)将步骤(2)所得的液体加热至110℃,在转速为250转/min下,将步骤(3)和步骤(4)所得的液体、以及步骤(5)和步骤(6)中所得的混合粉依次加入步骤(2)所得的液体中,保温25min后降至常温;(7) Heat the liquid obtained in step (2) to 110 ° C, and at a speed of 250 rpm, the liquid obtained in step (3) and step (4), and the liquid obtained in step (5) and step (6) The mixed powder of gained is added in the liquid of step (2) gained successively, is down to normal temperature after the insulation 25min;
(8)将织物按浴比为1:40放置在步骤(7)所得的混合液中浸渍50min,将浸渍后的织物取出,脱水6.5min;(8) placing the fabric in the mixed solution obtained in step (7) for 50 minutes at a bath ratio of 1:40, and soaking for 50 minutes, taking out the fabric after soaking, and dehydrating for 6.5 minutes;
(9)将步骤(8)中脱水后的织物放置在C波紫外线下进行消毒,照射波长为260nm,消毒时间25min;(9) Place the dehydrated fabric in step (8) under C-wave ultraviolet light for disinfection, the irradiation wavelength is 260nm, and the disinfection time is 25min;
(10)将织物上涂抹粘胶层,将网罩套在织物上即制得用于静脉闭合治疗后的偏心性压迫敷料。(10) Smear the viscose layer on the fabric, and put the mesh cover on the fabric to obtain an eccentric compressive dressing for venous closure treatment.
实施例3:一种用于静脉闭合治疗后的偏心性压迫敷料,包括止血纱布和包裹在止血纱布外用于防止止血纱布散开的网罩;网罩由弹性材料制成;网罩与止血纱布接触的一侧上设置有用于将止血纱布粘附在止血纱布上的粘胶层;粘胶层是由以下成分按质量份而成:6份荨麻根、8份白芨、3份蒲公英、4份连翘和3份马勃。Embodiment 3: An eccentric compression dressing for venous closure treatment, comprising hemostatic gauze and a mesh cover wrapped in the hemostatic gauze to prevent the hemostatic gauze from spreading; the mesh cover is made of elastic material; the mesh cover and the hemostatic gauze A viscose layer for adhering the hemostatic gauze to the hemostatic gauze is arranged on the contacting side; the viscose layer is made of the following components in parts by mass: 6 parts of nettle root, 8 parts of bletilla striata, 3 parts of dandelion, 4 parts by mass. 1 part forsythia and 3 parts puffball.
其中止血纱布包括织物、浸渍在织物上的止血药剂、杀菌消毒药剂、祛疤剂、镇痛剂和愈合剂;其中止血药剂、杀菌消毒药剂、祛疤剂、镇痛剂和愈合剂的质量比是1.53:0.9:0.4:0.2:0.5;Wherein the hemostatic gauze comprises fabric, the hemostatic agent impregnated on the fabric, bactericidal disinfectant, scar remover, analgesic and healing agent; wherein the mass ratio of hemostatic agent, bactericidal disinfectant, scar remover, analgesic and healing agent is 1.53:0.9:0.4:0.2:0.5;
止血药剂是由以下成分按质量份制备而成:8份黄龙尾、10份铁苋草、7份富贵菜、9份沙棘油、6份依地酸钠、4份三七、3份景天三七、3.5份芒硝、2.5份大黄、3份槐花、4份仙鹤草、4份艾叶、3份蒲黄;杀菌消毒药剂是由以下成分按质量份制备而成:11份桂皮、9份青叶丹、8份尾参和5份白芷;祛疤剂是由以下成分按质量份制备而成:9份芦荟汁、6份新鲜仙人掌汁和4份蜂蜜;镇痛剂是由以下成分按质量份制备而成:10份维生素B12、6份冰片、7份乳香和4份苏木;愈合剂是由以下成分按质量份制备而成:8份维生素B2、10份维生素B6和9份维生素C。The hemostatic agent is prepared from the following ingredients in parts by mass: 8 parts of huanglongwei, 10 parts of iron amaranth, 7 parts of rich cabbage, 9 parts of seabuckthorn oil, 6 parts of sodium edetate, 4 parts of Panax notoginseng, and 3 parts of sedum sedum Panax notoginseng, 3.5 parts of Glauber's salt, 2.5 parts of rhubarb, 3 parts of Sophora japonica, 4 parts of agrimony, 4 parts of mugwort leaves, and 3 parts of cattail; the sterilizing agent is prepared from the following ingredients by mass: 11 parts of cinnamon, 9 parts Qingye Dan, 8 parts of tail ginseng and 5 parts of Angelica dahurica; the scar remover is prepared from the following ingredients in parts by mass: 9 parts of aloe vera juice, 6 parts of fresh cactus juice and 4 parts of honey; the analgesic is made of the following ingredients in parts by mass Prepared by parts by mass: 10 parts of vitamin B12, 6 parts of borneol, 7 parts of frankincense and 4 parts of sumac; the healing agent is prepared by parts by mass of the following ingredients: 8 parts of vitamin B2, 10 parts of vitamin B6 and 9 parts of c.
该用于静脉闭合治疗后的偏心性压迫敷料的生产方法包括以下步骤:The production method of the eccentric compression dressing for venous closure therapy comprises the following steps:
(1)取总重量是8份黄龙尾、10份铁苋草、7份富贵菜、9份沙棘油和6份依地酸钠总重量4.7倍的纯净水并煮沸,依次向沸水中加入8份黄龙尾、10份铁苋草、7份富贵菜、9份沙棘油和6份依地酸钠,煎煮两次,每次煎煮2小时,合并煎煮后的煎液,并用微孔滤膜过滤;(1) Take 8 parts of Huanglongwei, 10 parts of Amaranth, 7 parts of Fuguicai, 9 parts of seabuckthorn oil and 6 parts of pure water 4.7 times the total weight of sodium edetate and boil it, and add 8 parts to the boiling water in turn. 1 part of Huanglongwei, 10 parts of iron amaranth, 7 parts of Fuguicai, 9 parts of seabuckthorn oil and 6 parts of edetate sodium, decocted twice, each time for 2 hours, combined the decoction after decoction, and used microporous Membrane filtration;
(2)向步骤(1)中所得滤液中加入4份三七、3份景天三七、3.5份芒硝、2.5份大黄、3份槐花、4份仙鹤草、4份艾叶、3份蒲黄,煎煮一次,煎煮时间为3小时,用微孔滤膜过滤,将滤液浓缩成相对密度为0.46的药液,备用;(2) Add 4 parts of notoginseng, 3 parts of sedum notoginseng, 3.5 parts of mirabilite, 2.5 parts of rhubarb, 3 parts of Sophora japonica, 4 parts of Agrimony, 4 parts of Artemisia argyi, 3 parts of cattail in the filtrate obtained in step (1) yellow, decocted once for 3 hours, filtered through a microporous membrane, and concentrated the filtrate into a medicinal liquid with a relative density of 0.46 for subsequent use;
(3)取总质量是11份桂皮、5份白芷、8份尾参总质量5.8倍的纯净水,向煮沸的水中加入11份桂皮、5份白芷、8份尾参,并煮沸,再加入9份青叶丹,煎煮三次,每次煎煮3小时,合并煎煮后的煎液,并用微孔滤膜过滤,将滤液浓缩成相对密度为0.43的药液,备用;(3) Take 11 parts of cassia bark, 5 parts of Angelica dahurica, and 8 parts of ginseng in pure water with a total mass of 5.8 times the total mass, add 11 parts of cinnamon bark, 5 parts of Angelica dahurica, and 8 parts of ginseng to the boiling water, and boil it, then add 9 parts of Qingye Dan were decocted three times, each time decocted for 3 hours, combined the decocted decoction, and filtered with a microporous membrane, and the filtrate was concentrated into a medicinal solution with a relative density of 0.43 for subsequent use;
(4)取9份芦荟汁,加热到110℃,在500转/min的转速下,向芦荟汁中缓慢加入6份仙人掌汁,搅拌均匀后升温至130℃,将转速提高至800转/min,向混合液中加入4份蜂蜜搅拌均匀,备用;(4) Take 9 parts of aloe vera juice, heat it to 110°C, slowly add 6 parts of cactus juice to the aloe vera juice at a speed of 500 rpm, stir evenly, heat up to 130°C, and increase the speed of rotation to 800 rpm , add 4 parts of honey to the mixture, stir evenly, and set aside;
(5)取6份冰片、7份乳香、4份苏木和10份维生素B12进行球磨粉碎,球料比为1.8:1,球磨时间为60min,备用;(5) Take 6 parts of borneol, 7 parts of frankincense, 4 parts of sumac and 10 parts of vitamin B12 and carry out ball milling, the ball-to-material ratio is 1.8:1, and the ball milling time is 60 minutes, and set aside;
(6)取8份维生素B2、10份维生素B6和9份维生素C进行球磨粉碎,球料比为1.6:1,球磨时间为50min,备用;(6) Take 8 parts of vitamin B2, 10 parts of vitamin B6 and 9 parts of vitamin C and carry out ball milling, the ball-to-material ratio is 1.6:1, and the ball milling time is 50 minutes, and set aside;
(7)将步骤(2)所得的液体加热至120℃,在转速为300转/min下,将步骤(3)和步骤(4)所得的液体、以及步骤(5)和步骤(6)中所得的混合粉依次加入步骤(2)所得的液体中,保温30min后降至常温;(7) Heat the liquid obtained in step (2) to 120 ° C, and at a speed of 300 rpm, the liquid obtained in step (3) and step (4), and the liquid obtained in step (5) and step (6) The mixed powder of gained is added in the liquid of step (2) gained successively, is down to normal temperature after the insulation 30min;
(8)将织物按浴比为1:50放置在步骤(7)所得的混合液中浸渍60min,将浸渍后的织物取出,脱水8min;(8) placing the fabric in the mixed solution obtained in step (7) for 60 minutes at a bath ratio of 1:50, and soaking for 60 minutes, taking out the fabric after soaking, and dehydrating for 8 minutes;
(9)将步骤(8)中脱水后的织物放置在C波紫外线下进行消毒,照射波长为270nm,消毒时间30min;(9) Place the dehydrated fabric in step (8) under C-wave ultraviolet light for disinfection, the irradiation wavelength is 270nm, and the disinfection time is 30min;
(10)将织物上涂抹粘胶层,将网罩套在织物上即制得用于静脉闭合治疗后的偏心性压迫敷料。(10) Smear the viscose layer on the fabric, and put the mesh cover on the fabric to obtain an eccentric compressive dressing for venous closure treatment.
对比例1:一种用于静脉闭合治疗后的偏心性压迫敷料,包括止血纱布和包裹在止血纱布外用于防止止血纱布散开的网罩;网罩由弹性材料制成;网罩与止血纱布接触的一侧上设置有用于将止血纱布粘附在止血纱布上的粘胶层;粘胶层是由以下成分按质量份而成:5份荨麻根、6.5份白芨、2.5份蒲公英、3.5份连翘和2份马勃。Comparative example 1: An eccentric compression dressing for venous closure treatment, including hemostatic gauze and a mesh cover wrapped outside the hemostatic gauze to prevent the hemostatic gauze from spreading; the mesh cover is made of elastic material; the mesh cover and the hemostatic gauze A viscose layer for adhering the hemostatic gauze to the hemostatic gauze is arranged on the contacting side; the viscose layer is made of the following components in parts by mass: 5 parts of nettle root, 6.5 parts of bletilla striata, 2.5 parts of dandelion, 3.5 parts of 1 part forsythia and 2 parts puffball.
其中止血纱布包括织物、浸渍在织物上的杀菌消毒药剂、祛疤剂、镇痛剂和愈合剂;其中杀菌消毒药剂、祛疤剂、镇痛剂和愈合剂的质量比是0.75:0.3:0.15:0.4;Wherein the hemostatic gauze comprises fabric, bactericidal disinfectant impregnated on the fabric, scar remover, analgesic and healing agent; wherein the mass ratio of bactericidal disinfectant, scar remover, analgesic and healer is 0.75:0.3:0.15 :0.4;
杀菌消毒药剂是由以下成分按质量份制备而成:10份桂皮、7份青叶丹、5.5份尾参和3.5份白芷;祛疤剂是由以下成分按质量份制备而成:6.5份芦荟汁、4份新鲜仙人掌汁和2.5份蜂蜜;镇痛剂是由以下成分按质量份制备而成:8份维生素B12、4.5份冰片、5.5份乳香和2.5份苏木;愈合剂是由以下成分按质量份制备而成:6份维生素B2、7.5份维生素B6和6.5份维生素C。The sterilizing and disinfecting agent is prepared by parts by mass of the following ingredients: 10 parts of cassia bark, 7 parts of Qingyedan, 5.5 parts of ginseng and 3.5 parts of Angelica dahurica; the scar remover is prepared by parts by mass of the following ingredients: 6.5 parts of aloe vera Juice, 4 parts of fresh cactus juice and 2.5 parts of honey; the analgesic is prepared from the following ingredients in parts by mass: 8 parts of vitamin B12, 4.5 parts of borneol, 5.5 parts of frankincense and 2.5 parts of sumac; the healing agent is made of the following ingredients Prepared by parts by mass: 6 parts of vitamin B2, 7.5 parts of vitamin B6 and 6.5 parts of vitamin C.
该用于静脉闭合治疗后的偏心性压迫敷料的生产方法包括以下步骤:The production method of the eccentric compression dressing for venous closure therapy comprises the following steps:
(1)取3份三七、2份景天三七、3份芒硝、2份大黄、2份槐花、3.5份仙鹤草、3.5份艾叶和2份蒲黄,煎煮一次,煎煮时间为2.5小时,用微孔滤膜过滤,将滤液浓缩成相对密度为0.46的药液,备用;(1) Take 3 parts of Panax notoginseng, 2 parts of Sedum Sanqi, 3 parts of Glauber's salt, 2 parts of rhubarb, 2 parts of Sophora japonica, 3.5 parts of Agrimony, 3.5 parts of Artemisia argyi and 2 parts of Puhuang, decoct once, decocting time For 2.5 hours, filter with a microporous membrane, concentrate the filtrate into a medicinal solution with a relative density of 0.46, and set aside;
(2)取总质量是10份桂皮、3.5份白芷和5.5份尾参总质量5.2倍的纯净水,向煮沸的水中加入10份桂皮、3.5份白芷和5.5份尾参,并煮沸,再加入7份青叶丹,煎煮三次,每次煎煮2.7小时,合并煎煮后的煎液,并用微孔滤膜过滤,将滤液浓缩成相对密度为0.43的药液,备用;(2) Take 10 parts of cassia bark, 3.5 parts of Angelica dahurica and 5.5 parts of ginseng in pure water with a total mass of 5.2 times, add 10 parts of cinnamon, 3.5 parts of Angelica dahurica and 5.5 parts of ginseng into the boiling water, and boil, then add 7 parts of Qingye Dan were decocted three times, each decocting for 2.7 hours, the decoction after merging was decocted, and filtered with a microporous membrane, and the filtrate was concentrated into a medicinal solution with a relative density of 0.43 for subsequent use;
(3)取6.5份芦荟汁,加热到95℃,在400转/min的转速下,向芦荟汁中缓慢加入4份仙人掌汁,搅拌均匀后升温至125℃,将转速提高至700转/min,向混合液中加入2.5份蜂蜜搅拌均匀,备用;(3) Take 6.5 parts of aloe vera juice, heat it to 95°C, slowly add 4 parts of cactus juice to the aloe vera juice at a speed of 400 rpm, stir evenly, heat up to 125°C, and increase the speed to 700 rpm , add 2.5 parts of honey to the mixture, stir evenly, set aside;
(4)取4.5份冰片、5.5份乳香、2.5份苏木和8份维生素B12进行球磨粉碎,球料比为1.8:1,球磨时间为40min,备用;(4) Take 4.5 parts of borneol, 5.5 parts of frankincense, 2.5 parts of hematoxylin and 8 parts of vitamin B12 and carry out ball milling, the ball-to-material ratio is 1.8:1, the ball milling time is 40min, and set aside;
(5)取6份维生素B2、7.5份维生素B6和6.5份维生素C进行球磨粉碎,球料比为1.6:1,球磨时间为40min,备用;(5) Take 6 parts of vitamin B2, 7.5 parts of vitamin B6 and 6.5 parts of vitamin C and carry out ball milling, the ball-to-material ratio is 1.6:1, and the ball milling time is 40 minutes, and set aside;
(6)将步骤(1)所得的液体加热至110℃,在转速为250转/min下,将步骤(2)和步骤(3)所得的液体、以及步骤(4)和步骤(5)中所得的混合粉依次加入步骤(1)所得的液体中,保温25min后降至常温;(6) Heat the liquid obtained in step (1) to 110 ° C, and at a speed of 250 rpm, the liquid obtained in step (2) and step (3), and the liquid obtained in step (4) and step (5) The mixed powder of gained is added in the liquid of step (1) gained successively, is down to normal temperature after the insulation 25min;
(7)将织物按浴比为1:40放置在步骤(6)所得的混合液中浸渍50min,将浸渍后的织物取出,脱水6.5min;(7) placing the fabric in the mixed solution obtained in step (6) for 50 minutes at a bath ratio of 1:40, and soaking for 50 minutes, taking out the fabric after soaking, and dehydrating for 6.5 minutes;
(8)将步骤(7)中脱水后的织物放置在C波紫外线下进行消毒,照射波长为260nm,消毒时间25min;(8) Place the dehydrated fabric in step (7) under C-wave ultraviolet light for disinfection, the irradiation wavelength is 260nm, and the disinfection time is 25min;
(9)将织物上涂抹粘胶层,将网罩套在织物上即制得用于静脉闭合治疗后的偏心性压迫敷料。(9) Smear the viscose layer on the fabric, and cover the mesh cover on the fabric to obtain an eccentric compressive dressing for venous closure treatment.
对比例2:一种用于静脉闭合治疗后的偏心性压迫敷料,包括止血纱布和包裹在止血纱布外用于防止止血纱布散开的网罩;网罩由弹性材料制成;网罩与止血纱布接触的一侧上设置有用于将止血纱布粘附在止血纱布上的粘胶层;粘胶层是由以下成分按质量份而成:5份荨麻根、6.5份白芨、2.5份蒲公英、3.5份连翘和2份马勃。Comparative example 2: An eccentric compression dressing for venous closure treatment, including hemostatic gauze and a mesh cover wrapped outside the hemostatic gauze to prevent the hemostatic gauze from spreading; the mesh cover is made of elastic material; the mesh cover and the hemostatic gauze A viscose layer for adhering the hemostatic gauze to the hemostatic gauze is arranged on the contacting side; the viscose layer is made of the following components in parts by mass: 5 parts of nettle root, 6.5 parts of bletilla striata, 2.5 parts of dandelion, 3.5 parts of 1 part forsythia and 2 parts puffball.
其中止血纱布包括织物、浸渍在织物上的止血药剂、祛疤剂、镇痛剂和愈合剂;其中止血药剂、祛疤剂、镇痛剂和愈合剂的质量比是1.4:0.3:0.15:0.4;Wherein the hemostatic gauze comprises fabric, hemostatic agent, scar remover, analgesic and healing agent impregnated on the fabric; wherein the mass ratio of hemostatic agent, scar remover, analgesic and healer is 1.4:0.3:0.15:0.4 ;
止血药剂是由以下成分按质量份制备而成:6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油、4.5份依地酸钠、3份三七、2份景天三七、3份芒硝、2份大黄、2份槐花、3.5份仙鹤草、3.5份艾叶和2份蒲黄;祛疤剂是由以下成分按质量份制备而成:6.5份芦荟汁、4份新鲜仙人掌汁和2.5份蜂蜜;镇痛剂是由以下成分按质量份制备而成:8份维生素B12、4.5份冰片、5.5份乳香和2.5份苏木;愈合剂是由以下成分按质量份制备而成:6份维生素B2、7.5份维生素B6和6.5份维生素C。The hemostatic agent is prepared from the following ingredients in parts by mass: 6.5 parts of huanglongwei, 9 parts of iron amaranth, 5.5 parts of rich cabbage, 7 parts of seabuckthorn oil, 4.5 parts of sodium edetate, 3 parts of Panax notoginseng, 2 parts of sedum sedum Panax notoginseng, 3 parts of mirabilite, 2 parts of rhubarb, 2 parts of Sophora japonica, 3.5 parts of agrimony, 3.5 parts of mugwort leaves and 2 parts of cattail; part of fresh cactus juice and 2.5 parts of honey; the analgesic is prepared from the following components by mass parts: 8 parts of vitamin B12, 4.5 parts of borneol, 5.5 parts of frankincense and 2.5 parts of sumac; the healing agent is made of the following components by mass parts Prepared with: 6 parts vitamin B2, 7.5 parts vitamin B6 and 6.5 parts vitamin C.
该用于静脉闭合治疗后的偏心性压迫敷料的生产方法包括以下步骤:The production method of the eccentric compression dressing for venous closure therapy comprises the following steps:
(1)取总重量是6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油和4.5份依地酸钠总重量4.1倍的纯净水并煮沸,依次向沸水中加入6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油和4.5份依地酸钠,煎煮两次,每次煎煮1。5小时,合并煎煮后的煎液,并用微孔滤膜过滤;(1) Take 6.5 parts of Huanglongwei, 9 parts of Amaranth, 5.5 parts of Fuguicai, 7 parts of seabuckthorn oil and 4.5 parts of pure water 4.1 times the total weight of sodium edetate and boil it, and add 6.5 parts to the boiling water in turn. 5 parts of Huanglongwei, 9 parts of iron amaranth, 5.5 parts of Fuguicai, 7 parts of seabuckthorn oil and 4.5 parts of edetate sodium, decocted twice, each time for 1.5 hours, combined the decocted decoction, and used Microporous membrane filtration;
(2)向步骤(1)中所得滤液中加入3份三七、2份景天三七、3份芒硝、2份大黄、2份槐花、3.5份仙鹤草、3.5份艾叶和2份蒲黄,煎煮一次,煎煮时间为2.5小时,用微孔滤膜过滤,将滤液浓缩成相对密度为0.46的药液,备用;(2) Add 3 parts of Panax notoginseng, 2 parts of Sedum notoginseng, 3 parts of Glauber's salt, 2 parts of rhubarb, 2 parts of Sophora japonica, 3.5 parts of Agrimony, 3.5 parts of Artemisia argyi and 2 parts of cattail in the filtrate obtained in step (1) Yellow, decocted once, the decoction time is 2.5 hours, filtered with a microporous membrane, and the filtrate is concentrated into a medicinal liquid with a relative density of 0.46, and set aside;
(3)取6.5份芦荟汁,加热到95℃,在400转/min的转速下,向芦荟汁中缓慢加入4份仙人掌汁,搅拌均匀后升温至125℃,将转速提高至700转/min,向混合液中加入2.5份蜂蜜搅拌均匀,备用;(3) Take 6.5 parts of aloe vera juice, heat it to 95°C, slowly add 4 parts of cactus juice to the aloe vera juice at a speed of 400 rpm, stir evenly, heat up to 125°C, and increase the speed to 700 rpm , add 2.5 parts of honey to the mixture, stir evenly, set aside;
(4)取4.5份冰片、5.5份乳香、2.5份苏木和8份维生素B12进行球磨粉碎,球料比为1.8:1,球磨时间为40min,备用;(4) Take 4.5 parts of borneol, 5.5 parts of frankincense, 2.5 parts of hematoxylin and 8 parts of vitamin B12 and carry out ball milling, the ball-to-material ratio is 1.8:1, the ball milling time is 40min, and set aside;
(5)取6份维生素B2、7.5份维生素B6和6.5份维生素C进行球磨粉碎,球料比为1.6:1,球磨时间为40min,备用;(5) Take 6 parts of vitamin B2, 7.5 parts of vitamin B6 and 6.5 parts of vitamin C and carry out ball milling, the ball-to-material ratio is 1.6:1, and the ball milling time is 40 minutes, and set aside;
(6)将步骤(2)所得的液体加热至110℃,在转速为250转/min下,将步骤(3)所得的液体、以及步骤(4)和步骤(5)中所得的混合粉依次加入步骤(2)所得的液体中,保温25min后降至常温;(6) Heat the liquid obtained in step (2) to 110 ° C, and at a speed of 250 rpm, the liquid obtained in step (3) and the mixed powder obtained in step (4) and step (5) are sequentially Add in the liquid of step (2) gained, be down to normal temperature after the insulation 25min;
(7)将织物按浴比为1:40放置在步骤(6)所得的混合液中浸渍50min,将浸渍后的织物取出,脱水6.5min;(7) placing the fabric in the mixed solution obtained in step (6) for 50 minutes at a bath ratio of 1:40, and soaking for 50 minutes, taking out the fabric after soaking, and dehydrating for 6.5 minutes;
(8)将步骤(7)中脱水后的织物放置在C波紫外线下进行消毒,照射波长为260nm,消毒时间25min;(8) Place the dehydrated fabric in step (7) under C-wave ultraviolet light for disinfection, the irradiation wavelength is 260nm, and the disinfection time is 25min;
(9)将织物上涂抹粘胶层,将网罩套在织物上即制得用于静脉闭合治疗后的偏心性压迫敷料。(9) Smear the viscose layer on the fabric, and cover the mesh cover on the fabric to obtain an eccentric compressive dressing for venous closure treatment.
对比例3:一种用于静脉闭合治疗后的偏心性压迫敷料,包括止血纱布和包裹在止血纱布外用于防止止血纱布散开的网罩;网罩由弹性材料制成;网罩与止血纱布接触的一侧上设置有用于将止血纱布粘附在止血纱布上的粘胶层;粘胶层是由以下成分按质量份而成:5份荨麻根、6.5份白芨、2.5份蒲公英、3.5份连翘和2份马勃。Comparative example 3: An eccentric compression dressing for venous closure treatment, including hemostatic gauze and a mesh cover wrapped outside the hemostatic gauze to prevent the hemostatic gauze from spreading; the mesh cover is made of elastic material; the mesh cover and the hemostatic gauze A viscose layer for adhering the hemostatic gauze to the hemostatic gauze is arranged on the contacting side; the viscose layer is made of the following components in parts by mass: 5 parts of nettle root, 6.5 parts of bletilla striata, 2.5 parts of dandelion, 3.5 parts of 1 part forsythia and 2 parts puffball.
其中止血纱布包括织物、浸渍在织物上的止血药剂、杀菌消毒药剂、镇痛剂和愈合剂;其中止血药剂、杀菌消毒药剂、镇痛剂和愈合剂的质量比是1.4:0.75:0.15:0.4;Wherein the hemostatic gauze comprises fabric, hemostatic agent, bactericidal disinfectant, analgesic and healing agent impregnated on the fabric; wherein the mass ratio of hemostatic agent, bactericidal disinfectant, analgesic and healing agent is 1.4:0.75:0.15:0.4 ;
止血药剂是由以下成分按质量份制备而成:6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油、4.5份依地酸钠、3份三七、2份景天三七、3份芒硝、2份大黄、2份槐花、3.5份仙鹤草、3.5份艾叶和2份蒲黄;杀菌消毒药剂是由以下成分按质量份制备而成:10份桂皮、7份青叶丹、5.5份尾参和3.5份白芷;镇痛剂是由以下成分按质量份制备而成:8份维生素B12、4.5份冰片、5.5份乳香和2.5份苏木;愈合剂是由以下成分按质量份制备而成:6份维生素B2、7.5份维生素B6和6.5份维生素C。The hemostatic agent is prepared from the following ingredients in parts by mass: 6.5 parts of huanglongwei, 9 parts of iron amaranth, 5.5 parts of rich cabbage, 7 parts of seabuckthorn oil, 4.5 parts of sodium edetate, 3 parts of Panax notoginseng, 2 parts of sedum sedum Panax notoginseng, 3 parts of Glauber's salt, 2 parts of rhubarb, 2 parts of Sophora japonica, 3.5 parts of Agrimony, 3.5 parts of Artemisia argyi and 2 parts of Puhuang; the sterilizing and disinfecting agent is prepared from the following ingredients by mass: 10 parts of cinnamon, 7 parts Qingye Dan, 5.5 parts of ginseng and 3.5 parts of Angelica dahurica; the analgesic is prepared from the following ingredients in parts by mass: 8 parts of vitamin B12, 4.5 parts of borneol, 5.5 parts of frankincense and 2.5 parts of sumac; the healing agent is made of the following The ingredients are prepared in parts by mass: 6 parts of vitamin B2, 7.5 parts of vitamin B6 and 6.5 parts of vitamin C.
该用于静脉闭合治疗后的偏心性压迫敷料的生产方法包括以下步骤:The production method of the eccentric compression dressing for venous closure therapy comprises the following steps:
(1)取总重量是6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油和4.5份依地酸钠总重量4.1倍的纯净水并煮沸,依次向沸水中加入6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油和4.5份依地酸钠,煎煮两次,每次煎煮1。5小时,合并煎煮后的煎液,并用微孔滤膜过滤;(1) Take 6.5 parts of Huanglongwei, 9 parts of Amaranth, 5.5 parts of Fuguicai, 7 parts of seabuckthorn oil and 4.5 parts of pure water 4.1 times the total weight of sodium edetate and boil it, and add 6.5 parts to the boiling water in turn. 5 parts of Huanglongwei, 9 parts of iron amaranth, 5.5 parts of Fuguicai, 7 parts of seabuckthorn oil and 4.5 parts of edetate sodium, decocted twice, each time for 1.5 hours, combined the decocted decoction, and used Microporous membrane filtration;
(2)向步骤(1)中所得滤液中加入3份三七、2份景天三七、3份芒硝、2份大黄、2份槐花、3.5份仙鹤草、3.5份艾叶和2份蒲黄,煎煮一次,煎煮时间为2.5小时,用微孔滤膜过滤,将滤液浓缩成相对密度为0.46的药液,备用;(2) Add 3 parts of Panax notoginseng, 2 parts of Sedum notoginseng, 3 parts of Glauber's salt, 2 parts of rhubarb, 2 parts of Sophora japonica, 3.5 parts of Agrimony, 3.5 parts of Artemisia argyi and 2 parts of cattail in the filtrate obtained in step (1) Yellow, decocted once, the decoction time is 2.5 hours, filtered with a microporous membrane, the filtrate is concentrated into a medicinal liquid with a relative density of 0.46, and set aside;
(3)取总质量是10份桂皮、3.5份白芷和5.5份尾参总质量5.2倍的纯净水,向煮沸的水中加入10份桂皮、3.5份白芷和5.5份尾参,并煮沸,再加入7份青叶丹,煎煮三次,每次煎煮2.7小时,合并煎煮后的煎液,并用微孔滤膜过滤,将滤液浓缩成相对密度为0.43的药液,备用;(3) Take the pure water whose total mass is 10 parts of cinnamon, 3.5 parts of Angelica dahurica and 5.5 parts of tail ginseng 5.2 times the total mass, add 10 parts of cinnamon, 3.5 parts of Angelica dahurica and 5.5 parts of tail ginseng to the boiling water, and boil it, then add 7 parts of Qingye Dan were decocted three times, each decocting for 2.7 hours, the decoction after merging was decocted, and filtered with a microporous membrane, and the filtrate was concentrated into a medicinal solution with a relative density of 0.43 for subsequent use;
(4)取4.5份冰片、5.5份乳香、2.5份苏木和8份维生素B12进行球磨粉碎,球料比为1.8:1,球磨时间为40min,备用;(4) Take 4.5 parts of borneol, 5.5 parts of frankincense, 2.5 parts of hematoxylin and 8 parts of vitamin B12 and carry out ball milling, the ball-to-material ratio is 1.8:1, and the ball milling time is 40 minutes, and set aside;
(5)取6份维生素B2、7.5份维生素B6和6.5份维生素C进行球磨粉碎,球料比为1.6:1,球磨时间为40min,备用;(5) Take 6 parts of vitamin B2, 7.5 parts of vitamin B6 and 6.5 parts of vitamin C and carry out ball milling, the ball-to-material ratio is 1.6:1, the ball milling time is 40min, and set aside;
(6)将步骤(2)所得的液体加热至110℃,在转速为250转/min下,将步骤(3)所得的液体、以及步骤(4)和步骤(5)中所得的混合粉依次加入步骤(2)所得的液体中,保温25min后降至常温;(6) Heat the liquid obtained in step (2) to 110 ° C, and at a speed of 250 rpm, the liquid obtained in step (3) and the mixed powder obtained in step (4) and step (5) are sequentially Add in the liquid of step (2) gained, be down to normal temperature after the insulation 25min;
(7)将织物按浴比为1:40放置在步骤(6)所得的混合液中浸渍50min,将浸渍后的织物取出,脱水6.5min;(7) placing the fabric in the mixed solution obtained in step (6) for 50 minutes at a bath ratio of 1:40, and soaking for 50 minutes, taking out the fabric after soaking, and dehydrating for 6.5 minutes;
(8)将步骤(7)中脱水后的织物放置在C波紫外线下进行消毒,照射波长为260nm,消毒时间25min;(8) Place the dehydrated fabric in step (7) under C-wave ultraviolet light for disinfection, the irradiation wavelength is 260nm, and the disinfection time is 25min;
(9)将织物上涂抹粘胶层,将网罩套在织物上即制得用于静脉闭合治疗后的偏心性压迫敷料。(9) Smear the viscose layer on the fabric, and cover the mesh cover on the fabric to obtain an eccentric compressive dressing for venous closure treatment.
对比例4:一种用于静脉闭合治疗后的偏心性压迫敷料,包括止血纱布和包裹在止血纱布外用于防止止血纱布散开的网罩;网罩由弹性材料制成;网罩与止血纱布接触的一侧上设置有用于将止血纱布粘附在止血纱布上的粘胶层;粘胶层是由以下成分按质量份而成:5份荨麻根、6.5份白芨、2.5份蒲公英、3.5份连翘和2份马勃。Comparative example 4: An eccentric compression dressing for venous closure treatment, including hemostatic gauze and a mesh cover wrapped outside the hemostatic gauze to prevent the hemostatic gauze from spreading; the mesh cover is made of elastic material; the mesh cover and the hemostatic gauze A viscose layer for adhering the hemostatic gauze to the hemostatic gauze is arranged on the contacting side; the viscose layer is made of the following components in parts by mass: 5 parts of nettle root, 6.5 parts of bletilla striata, 2.5 parts of dandelion, 3.5 parts of 1 part forsythia and 2 parts puffball.
其中止血纱布包括织物、浸渍在织物上的止血药剂、杀菌消毒药剂、祛疤剂、镇痛剂和愈合剂;其中止血药剂、杀菌消毒药剂、祛疤剂、愈合剂的质量比是1.4:0.75:0.3:0.4;Wherein the hemostatic gauze comprises fabric, the hemostatic agent impregnated on the fabric, sterilizing and disinfecting agent, scar removing agent, analgesic and healing agent; wherein the mass ratio of hemostatic agent, sterilizing and disinfecting agent, scar removing agent and healing agent is 1.4:0.75 :0.3:0.4;
止血药剂是由以下成分按质量份制备而成:6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油、4.5份依地酸钠、3份三七、2份景天三七、3份芒硝、2份大黄、2份槐花、3.5份仙鹤草、3.5份艾叶和2份蒲黄;杀菌消毒药剂是由以下成分按质量份制备而成:10份桂皮、7份青叶丹、5.5份尾参和3.5份白芷;祛疤剂是由以下成分按质量份制备而成:6.5份芦荟汁、4份新鲜仙人掌汁和2.5份蜂蜜;愈合剂是由以下成分按质量份制备而成:6份维生素B2、7.5份维生素B6和6.5份维生素C。The hemostatic agent is prepared from the following ingredients in parts by mass: 6.5 parts of huanglongwei, 9 parts of iron amaranth, 5.5 parts of rich cabbage, 7 parts of seabuckthorn oil, 4.5 parts of sodium edetate, 3 parts of Panax notoginseng, 2 parts of sedum sedum Panax notoginseng, 3 parts of Glauber's salt, 2 parts of rhubarb, 2 parts of Sophora japonica, 3.5 parts of Agrimony, 3.5 parts of Artemisia argyi and 2 parts of Puhuang; the sterilizing and disinfecting agent is prepared from the following ingredients by mass: 10 parts of cinnamon, 7 parts Qingye Dan, 5.5 parts of ginseng and 3.5 parts of Angelica dahurica; the scar remover is prepared from the following ingredients by mass parts: 6.5 parts of aloe vera juice, 4 parts of fresh cactus juice and 2.5 parts of honey; the healing agent is made of the following ingredients by mass prepared from: 6 parts vitamin B2, 7.5 parts vitamin B6 and 6.5 parts vitamin C.
该用于静脉闭合治疗后的偏心性压迫敷料的生产方法包括以下步骤:The production method of the eccentric compression dressing for venous closure therapy comprises the following steps:
(1)取总重量是6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油和4.5份依地酸钠总重量4.1倍的纯净水并煮沸,依次向沸水中加入6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油和4.5份依地酸钠,煎煮两次,每次煎煮1。5小时,合并煎煮后的煎液,并用微孔滤膜过滤;(1) Take 6.5 parts of Huanglongwei, 9 parts of Amaranth, 5.5 parts of Fuguicai, 7 parts of seabuckthorn oil and 4.5 parts of pure water 4.1 times the total weight of sodium edetate and boil it, and add 6.5 parts to the boiling water in turn. 5 parts of Huanglongwei, 9 parts of iron amaranth, 5.5 parts of Fuguicai, 7 parts of seabuckthorn oil and 4.5 parts of edetate sodium, decocted twice, each time for 1.5 hours, combined the decocted decoction, and used Microporous membrane filtration;
(2)向步骤(1)中所得滤液中加入3份三七、2份景天三七、3份芒硝、2份大黄、2份槐花、3.5份仙鹤草、3.5份艾叶和2份蒲黄,煎煮一次,煎煮时间为2.5小时,用微孔滤膜过滤,将滤液浓缩成相对密度为0.46的药液,备用;(2) Add 3 parts of Panax notoginseng, 2 parts of Sedum notoginseng, 3 parts of Glauber's salt, 2 parts of rhubarb, 2 parts of Sophora japonica, 3.5 parts of Agrimony, 3.5 parts of Artemisia argyi and 2 parts of cattail in the filtrate obtained in step (1) Yellow, decocted once, the decoction time is 2.5 hours, filtered with a microporous membrane, and the filtrate is concentrated into a medicinal liquid with a relative density of 0.46, and set aside;
(3)取总质量是10份桂皮、3.5份白芷和5.5份尾参总质量5.2倍的纯净水,向煮沸的水中加入10份桂皮、3.5份白芷和5.5份尾参,并煮沸,再加入7份青叶丹,煎煮三次,每次煎煮2.7小时,合并煎煮后的煎液,并用微孔滤膜过滤,将滤液浓缩成相对密度为0.43的药液,备用;(3) Take the pure water whose total mass is 10 parts of cinnamon, 3.5 parts of Angelica dahurica and 5.5 parts of tail ginseng 5.2 times the total mass, add 10 parts of cinnamon, 3.5 parts of Angelica dahurica and 5.5 parts of tail ginseng to the boiling water, and boil it, then add 7 parts of Qingye Dan were decocted three times, each decocting for 2.7 hours, the decoction after merging was decocted, and filtered with a microporous membrane, and the filtrate was concentrated into a medicinal solution with a relative density of 0.43 for subsequent use;
(4)取6.5份芦荟汁,加热到95℃,在400转/min的转速下,向芦荟汁中缓慢加入4份仙人掌汁,搅拌均匀后升温至125℃,将转速提高至700转/min,向混合液中加入2.5份蜂蜜搅拌均匀,备用;(4) Take 6.5 parts of aloe vera juice, heat it to 95°C, slowly add 4 parts of cactus juice to the aloe vera juice at a speed of 400 rpm, stir evenly, heat up to 125°C, and increase the speed to 700 rpm , add 2.5 parts of honey to the mixture, stir evenly, set aside;
(5)取6份维生素B2、7.5份维生素B6和6.5份维生素C进行球磨粉碎,球料比为1.6:1,球磨时间为40min,备用;(5) Take 6 parts of vitamin B2, 7.5 parts of vitamin B6 and 6.5 parts of vitamin C and carry out ball milling, the ball-to-material ratio is 1.6:1, and the ball milling time is 40 minutes, and set aside;
(6)将步骤(2)所得的液体加热至110℃,在转速为250转/min下,将步骤(3)和步骤(4)所得的液体、以及步骤(5)中所得的混合粉依次加入步骤(2)所得的液体中,保温25min后降至常温;(6) Heat the liquid obtained in step (2) to 110 ° C, and at a speed of 250 rpm, the liquid obtained in step (3) and step (4) and the mixed powder obtained in step (5) are sequentially Add in the liquid of step (2) gained, be down to normal temperature after the insulation 25min;
(7)将织物按浴比为1:40放置在步骤(6)所得的混合液中浸渍50min,将浸渍后的织物取出,脱水6.5min;(7) placing the fabric in the mixed solution obtained in step (6) for 50 minutes at a bath ratio of 1:40, and soaking for 50 minutes, taking out the fabric after soaking, and dehydrating for 6.5 minutes;
(8)将步骤(7)中脱水后的织物放置在C波紫外线下进行消毒,照射波长为260nm,消毒时间25min;(8) Place the dehydrated fabric in step (7) under C-wave ultraviolet light for disinfection, the irradiation wavelength is 260nm, and the disinfection time is 25min;
(9)将织物上涂抹粘胶层,将网罩套在织物上即制得用于静脉闭合治疗后的偏心性压迫敷料。(9) Smear the viscose layer on the fabric, and cover the mesh cover on the fabric to obtain an eccentric compressive dressing for venous closure treatment.
对比例5:一种用于静脉闭合治疗后的偏心性压迫敷料,包括止血纱布和包裹在止血纱布外用于防止止血纱布散开的网罩;网罩由弹性材料制成;网罩与止血纱布接触的一侧上设置有用于将止血纱布粘附在止血纱布上的粘胶层;粘胶层是由以下成分按质量份而成:5份荨麻根、6.5份白芨、2.5份蒲公英、3.5份连翘和2份马勃。Comparative example 5: An eccentric compression dressing for venous closure treatment, including hemostatic gauze and a mesh cover wrapped outside the hemostatic gauze to prevent the hemostatic gauze from spreading; the mesh cover is made of elastic material; the mesh cover and the hemostatic gauze A viscose layer for adhering the hemostatic gauze to the hemostatic gauze is arranged on the contacting side; the viscose layer is made of the following components in parts by mass: 5 parts of nettle root, 6.5 parts of bletilla striata, 2.5 parts of dandelion, 3.5 parts of 1 part forsythia and 2 parts puffball.
其中止血纱布包括织物、浸渍在织物上的止血药剂、杀菌消毒药剂、祛疤剂、镇痛剂和愈合剂;其中止血药剂、杀菌消毒药剂、祛疤剂、镇痛剂的质量比是1.4:0.75:0.3:0.15;Wherein the hemostatic gauze comprises fabric, the hemostatic agent impregnated on the fabric, bactericidal disinfectant, scar remover, analgesic and healing agent; wherein the mass ratio of hemostatic agent, bactericidal disinfectant, scar remover, analgesic is 1.4: 0.75:0.3:0.15;
止血药剂是由以下成分按质量份制备而成:6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油、4.5份依地酸钠、3份三七、2份景天三七、3份芒硝、2份大黄、2份槐花、3.5份仙鹤草、3.5份艾叶和2份蒲黄;杀菌消毒药剂是由以下成分按质量份制备而成:10份桂皮、7份青叶丹、5.5份尾参和3.5份白芷;祛疤剂是由以下成分按质量份制备而成:6.5份芦荟汁、4份新鲜仙人掌汁和2.5份蜂蜜;镇痛剂是由以下成分按质量份制备而成:8份维生素B12、4.5份冰片、5.5份乳香和2.5份苏木。The hemostatic agent is prepared from the following ingredients in parts by mass: 6.5 parts of huanglongwei, 9 parts of iron amaranth, 5.5 parts of rich cabbage, 7 parts of seabuckthorn oil, 4.5 parts of sodium edetate, 3 parts of Panax notoginseng, 2 parts of sedum sedum Panax notoginseng, 3 parts of Glauber's salt, 2 parts of rhubarb, 2 parts of Sophora japonica, 3.5 parts of Agrimony, 3.5 parts of Artemisia argyi and 2 parts of Puhuang; the sterilizing and disinfecting agent is prepared from the following ingredients by mass: 10 parts of cinnamon, 7 parts Qingye Dan, 5.5 parts of ginseng and 3.5 parts of Angelica dahurica; the scar remover is prepared from the following components by mass parts: 6.5 parts of aloe vera juice, 4 parts of fresh cactus juice and 2.5 parts of honey; the analgesic is made of the following components by weight Prepared in parts by mass: 8 parts of vitamin B12, 4.5 parts of borneol, 5.5 parts of frankincense and 2.5 parts of sumac.
该用于静脉闭合治疗后的偏心性压迫敷料的生产方法包括以下步骤:The production method of the eccentric compression dressing for venous closure therapy comprises the following steps:
(1)取总重量是6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油和4.5份依地酸钠总重量4.1倍的纯净水并煮沸,依次向沸水中加入6.5份黄龙尾、9份铁苋草、5.5份富贵菜、7份沙棘油和4.5份依地酸钠,煎煮两次,每次煎煮1。5小时,合并煎煮后的煎液,并用微孔滤膜过滤;(1) Take 6.5 parts of Huanglongwei, 9 parts of Amaranth, 5.5 parts of Fuguicai, 7 parts of seabuckthorn oil and 4.5 parts of pure water 4.1 times the total weight of sodium edetate and boil it, and add 6.5 parts to the boiling water in turn. 5 parts of Huanglongwei, 9 parts of iron amaranth, 5.5 parts of Fuguicai, 7 parts of seabuckthorn oil and 4.5 parts of edetate sodium, decocted twice, each time for 1.5 hours, combined the decocted decoction, and used Microporous membrane filtration;
(2)向步骤(1)中所得滤液中加入3份三七、2份景天三七、3份芒硝、2份大黄、2份槐花、3.5份仙鹤草、3.5份艾叶和2份蒲黄,煎煮一次,煎煮时间为2.5小时,用微孔滤膜过滤,将滤液浓缩成相对密度为0.46的药液,备用;(2) Add 3 parts of Panax notoginseng, 2 parts of Sedum notoginseng, 3 parts of Glauber's salt, 2 parts of rhubarb, 2 parts of Sophora japonica, 3.5 parts of Agrimony, 3.5 parts of Artemisia argyi and 2 parts of cattail in the filtrate obtained in step (1) Yellow, decocted once, the decoction time is 2.5 hours, filtered with a microporous membrane, and the filtrate is concentrated into a medicinal liquid with a relative density of 0.46, and set aside;
(3)取总质量是10份桂皮、3.5份白芷和5.5份尾参总质量5.2倍的纯净水,向煮沸的水中加入10份桂皮、3.5份白芷和5.5份尾参,并煮沸,再加入7份青叶丹,煎煮三次,每次煎煮2.7小时,合并煎煮后的煎液,并用微孔滤膜过滤,将滤液浓缩成相对密度为0.43的药液,备用;(3) Take the pure water whose total mass is 10 parts of cinnamon, 3.5 parts of Angelica dahurica and 5.5 parts of tail ginseng 5.2 times the total mass, add 10 parts of cinnamon, 3.5 parts of Angelica dahurica and 5.5 parts of tail ginseng to the boiling water, and boil it, then add 7 parts of Qingye Dan were decocted three times, each decocting for 2.7 hours, the decoction after merging was decocted, and filtered with a microporous membrane, and the filtrate was concentrated into a medicinal solution with a relative density of 0.43 for subsequent use;
(4)取6.5份芦荟汁,加热到95℃,在400转/min的转速下,向芦荟汁中缓慢加入4份仙人掌汁,搅拌均匀后升温至125℃,将转速提高至700转/min,向混合液中加入2.5份蜂蜜搅拌均匀,备用;(4) Take 6.5 parts of aloe vera juice, heat it to 95°C, slowly add 4 parts of cactus juice to the aloe vera juice at a speed of 400 rpm, stir evenly, heat up to 125°C, and increase the speed to 700 rpm , add 2.5 parts of honey to the mixture, stir evenly, set aside;
(5)取4.5份冰片、5.5份乳香、2.5份苏木和8份维生素B12进行球磨粉碎,球料比为1.8:1,球磨时间为40min,备用;(5) Take 4.5 parts of borneol, 5.5 parts of frankincense, 2.5 parts of hematoxylin and 8 parts of vitamin B12 for ball milling and pulverization, the ball-to-material ratio is 1.8:1, and the ball milling time is 40 minutes, and set aside;
(6)将步骤(2)所得的液体加热至110℃,在转速为250转/min下,将步骤(3)和步骤(4)所得的液体、以及步骤(5)中所得的混合粉依次加入步骤(2)所得的液体中,保温25min后降至常温;(6) Heat the liquid obtained in step (2) to 110 ° C, and at a speed of 250 rpm, the liquid obtained in step (3) and step (4) and the mixed powder obtained in step (5) are sequentially Add in the liquid of step (2) gained, be down to normal temperature after the insulation 25min;
(7)将织物按浴比为1:40放置在步骤(6)所得的混合液中浸渍50min,将浸渍后的织物取出,脱水6.5min;(7) placing the fabric in the mixed solution obtained in step (6) for 50 minutes at a bath ratio of 1:40, and soaking for 50 minutes, taking out the fabric after soaking, and dehydrating for 6.5 minutes;
(8)将步骤(7)中脱水后的织物放置在C波紫外线下进行消毒,照射波长为260nm,消毒时间25min;(8) Place the dehydrated fabric in step (7) under C-wave ultraviolet light for disinfection, the irradiation wavelength is 260nm, and the disinfection time is 25min;
(9)将织物上涂抹粘胶层,将网罩套在织物上即制得用于静脉闭合治疗后的偏心性压迫敷料。(9) Smear the viscose layer on the fabric, and cover the mesh cover on the fabric to obtain an eccentric compressive dressing for venous closure treatment.
各实施例和各对比例中各成分的用量如表1所示:The consumption of each composition in each embodiment and each comparative example is as shown in table 1:
表1各实施例和各对比例中各成分用量表In each embodiment of table 1 and each comparative example, each component consumption table
止血实验:将实验家兔平均分为7组,包括实施例1-2和对比例1-5,将实验兔耳部脱毛、消毒,无菌条件下于家兔耳缘末1/3处,用消毒手术刀切开1cm长的出血口,其中包括耳中央一主动脉被切开,但耳朵并不透彻,防止血液从内侧流出,待血液充满创面后进行后续凝血测试,称量用于静脉闭合治疗后的偏心性压迫敷料的质量(m1),压破止血,10s后拿开用于静脉闭合治疗后的偏心性压迫敷料,观察止血效果。无更多血液从出血口处流出时记录时间T1,以后每5s观察一次,直至完全止血,记录时间T2,止血时间为T1和T2的平均值。止血完成后,称取吸入血液的用于静脉闭合治疗后的偏心性压迫敷料的质量(m2),计算出血量m=m2-m1。Hemostasis test: The experimental rabbits were divided into 7 groups on average, including Examples 1-2 and Comparative Examples 1-5. The ears of the experimental rabbits were depilated and sterilized. Use a sterile scalpel to incise a 1cm-long bleeding port, including an aorta in the center of the ear, but the ear is not thorough to prevent blood from flowing out from the inside. After the blood fills the wound, follow-up coagulation tests are performed and weighed for vein The mass (m 1 ) of the eccentric compressive dressing after the occlusive treatment was crushed to stop bleeding, and the eccentric compressive dressing used after the venous occlusive treatment was removed after 10 seconds to observe the hemostatic effect. When no more blood flows out from the bleeding port, record time T 1 , and then observe every 5 seconds until complete hemostasis, record time T 2 , and the hemostatic time is the average value of T 1 and T 2 . After the hemostasis is completed, the mass (m 2 ) of the eccentric compressive dressing used for venous closure after the inhaled blood is weighed, and the amount of bleeding m=m 2 −m 1 is calculated.
愈合实验:将小鼠平均分为7组,包括实施例1-2和对比例1-5,用3%戊巴比妥钠30mg/kg腹腔内注射麻醉,将小鼠背部脊柱两侧脱毛,脱毛面积4cm2,用开水将脱毛区烫伤,用用于静脉闭合治疗后的偏心性压迫敷料覆盖创伤面,每日换药一次。Healing experiment: the mice were divided into 7 groups on average, including Examples 1-2 and Comparative Examples 1-5, anesthetized by intraperitoneal injection of 3% pentobarbital sodium 30mg/kg, depilated on both sides of the back spine of the mice, The depilated area was 4cm 2 , and the depilated area was scalded with boiling water, and the wound surface was covered with an eccentric compression dressing used for venous closure treatment, and the dressing was changed once a day.
表1用于静脉闭合治疗后的偏心性压迫敷料的各项性能指标Table 1 The performance indicators of eccentric compression dressings used after venous closure therapy
由表1中用于静脉闭合治疗后的偏心性压迫敷料的各项性能指标可知,实施例1-3中添加止血药剂、杀菌消毒药剂、祛疤剂、镇痛剂和愈合剂,缩短了出血时间、降低出血量、无感染现象、没有疤痕、无焦躁不安现象并且愈合时间短;对比例1中无黄龙尾、铁苋草、富贵菜、沙棘油、依地酸钠,止血时间明显较长,出血量较大;对比例2中杀菌消毒药剂,出血口处出现感染现象;对比例3中无祛疤剂,出血口处留有疤痕;对比例4中无镇痛剂;家兔和小鼠出现严重焦躁不安现象;对比例5中无愈合剂,小鼠创伤面的愈合时间较长;因此黄龙尾、铁苋草、富贵菜、沙棘油、依地酸钠能够缩短止血时间,降低出血量;杀菌消毒药剂能够抑制细菌滋长,使出创伤面无感染现象;祛疤剂能够防腐生肌,使创伤面无疤痕;镇痛剂能够消肿止痛;愈合剂能够促进伤口愈合,缩短愈合时间。From the various performance indicators of the eccentric compressive dressing used in Table 1 after venous closure treatment, adding hemostatic agents, sterilizing and disinfecting agents, scar-removing agents, analgesics and healing agents in Examples 1-3 shortened the bleeding Time, reduce bleeding, no infection, no scar, no restlessness and short healing time; in comparative example 1, there is no yellow dragon tail, iron amaranth, rich cabbage, seabuckthorn oil, sodium edetate, and the hemostasis time is significantly longer , the amount of bleeding is large; in comparative example 2, sterilizing and disinfecting agents, infection occurs at the bleeding port; in comparative example 3, there is no scar removing agent, and scars are left at the bleeding port; in comparative example 4, there is no analgesic; Severe restlessness appeared in the mice; there was no healing agent in Comparative Example 5, and the healing time of the wound surface of the mice was longer; therefore, Huanglongwei, Amaranth, Fuguicai, seabuckthorn oil, and sodium edetate can shorten the hemostasis time and reduce bleeding Bactericidal and disinfectant can inhibit the growth of bacteria, so that there is no infection on the wound surface; scar remover can antiseptic and promote muscle growth, so that there is no scar on the wound surface; analgesic can reduce swelling and pain; healing agent can promote wound healing and shorten the healing time .
以上所述仅是本发明的优选实施方式,本发明的保护范围并不仅局限于上述实施例,凡属于本发明思路下的技术方案均属于本发明的保护范围。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理前提下的若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above descriptions are only preferred implementations of the present invention, and the protection scope of the present invention is not limited to the above-mentioned embodiments, and all technical solutions under the idea of the present invention belong to the protection scope of the present invention. It should be pointed out that for those skilled in the art, some improvements and modifications without departing from the principles of the present invention should also be regarded as the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810714443.5A CN108837173A (en) | 2018-06-29 | 2018-06-29 | A kind of eccentric sexual oppression dressing and its production method being closed after treatment for vein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810714443.5A CN108837173A (en) | 2018-06-29 | 2018-06-29 | A kind of eccentric sexual oppression dressing and its production method being closed after treatment for vein |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108837173A true CN108837173A (en) | 2018-11-20 |
Family
ID=64201120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810714443.5A Pending CN108837173A (en) | 2018-06-29 | 2018-06-29 | A kind of eccentric sexual oppression dressing and its production method being closed after treatment for vein |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108837173A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN202751503U (en) * | 2012-08-16 | 2013-02-27 | 浙江省肿瘤医院 | A kind of medical gauze net cover |
CN104161995A (en) * | 2014-08-25 | 2014-11-26 | 河南科技大学第一附属医院 | Bleeding stopping and blood coagulating powder used for traumatic hemorrhage and preparation method thereof |
CN105194560A (en) * | 2015-10-23 | 2015-12-30 | 亓亮 | Traditional Chinese medicinal composition for treating general surgical wound |
CN105311391A (en) * | 2015-01-26 | 2016-02-10 | 杨家驥 | Chinese herbal medicine for treating open wound and preparation method thereof |
US9295700B1 (en) * | 2015-11-17 | 2016-03-29 | Abdulmohsen Ebrahim Al-Terki | Wound healing composition |
-
2018
- 2018-06-29 CN CN201810714443.5A patent/CN108837173A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN202751503U (en) * | 2012-08-16 | 2013-02-27 | 浙江省肿瘤医院 | A kind of medical gauze net cover |
CN104161995A (en) * | 2014-08-25 | 2014-11-26 | 河南科技大学第一附属医院 | Bleeding stopping and blood coagulating powder used for traumatic hemorrhage and preparation method thereof |
CN105311391A (en) * | 2015-01-26 | 2016-02-10 | 杨家驥 | Chinese herbal medicine for treating open wound and preparation method thereof |
CN105194560A (en) * | 2015-10-23 | 2015-12-30 | 亓亮 | Traditional Chinese medicinal composition for treating general surgical wound |
US9295700B1 (en) * | 2015-11-17 | 2016-03-29 | Abdulmohsen Ebrahim Al-Terki | Wound healing composition |
Non-Patent Citations (5)
Title |
---|
张浩主编: "《心脏手术患者住院与康复指南》", 30 April 2016, 上海:上海科学技术出版社 * |
权正良编: "《高等院校急救手册》", 31 October 2012, 西安:陕西科学技术出版社 * |
李文汉等: "《儿科临床药理学》", 31 July 1998, 北京:人民卫生出版社 * |
邱方等: "《弥散性血管内凝血 诊治重点与典型病例》", 30 November 2017, 北京:科学技术文献出版社 * |
顾学裘编著: "《药物制剂注解》", 31 May 1965, 北京:人民卫生出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104758977B (en) | A kind of alginate dressing for treating bedsore and preparation method thereof | |
CN101310748B (en) | Ointment for treating empyrosis | |
CN101543565B (en) | Chinese medicine external-use preparation medicament for treating surgery wound infection and method for producing the same | |
CN102198159B (en) | Medicament for the treatment of burns and sore and ulcer diseases, and wound plaster made of the same | |
CN112294877B (en) | Medical gel with antibacterial and anti-inflammatory effects | |
CN101569696A (en) | Chinese medicament for traumatic wound | |
CN108939140A (en) | Composition for hemostasis and medical hemostatic dressing | |
CN102357203B (en) | Cortex ulmis burn ointment for curing burns | |
CN108686103B (en) | Hemostatic traditional Chinese medicine composition and multifunctional emergency hemostatic composite material | |
CN103585347B (en) | Chinese medicinal composition for treating burns and scalds and preparation method thereof | |
CN105233271B (en) | A kind of anti-scar salamander collagen burn cream and preparation method thereof | |
CN103223077B (en) | Traditional Chinese medicine composition for treating burn and scald | |
CN108837173A (en) | A kind of eccentric sexual oppression dressing and its production method being closed after treatment for vein | |
CN105477195A (en) | Medicine for treating skin injury and preparation method of medicine | |
CN102293783B (en) | Traditional Chinese medicinal composition for treating bedsore | |
CN101152290B (en) | Externally used powder preparation stypticum | |
CN109045204A (en) | A kind of herb liquid and preparation method thereof for treating burn and scald | |
CN104189304B (en) | It is a kind of to be used to treat Chinese medicine composition of surgical wound and preparation method thereof | |
CN103705678A (en) | Traditional Chinese medicinal oil for treating bedsores | |
CN102028875A (en) | Medicament for treating open wound and preparation method thereof | |
CN1323703C (en) | Enteric agent for treating acute and chronic gastroenteritis and preparing method | |
CN105561382A (en) | Dendrobium officinale liquid woundplast and preparation method thereof | |
CN104435566A (en) | External medicine for treating animal wound and preparation method of external medicine | |
CN104147172A (en) | Muscle regeneration promoting medicine for treating burns and scalds | |
CN115025162B (en) | Preparation method of compound tea oil burn ointment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181120 |